MEK2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| O00170 | T48 | Sugiyama | AIP XAP2 | FQDGTKATFHYRtLHsDDEGtVLDDsRARGKPMELIIGKKF |
| O14818 | T152 | Sugiyama | PSMA7 HSPC | LIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFL |
| O14979 | T165 | Sugiyama | HNRNPDL HNRPDL JKTBP | QDDGKMFIGGLSWDTsKKDLtEyLSRFGEVVDCtIKTDPVT |
| O15042 | S485 | Sugiyama | U2SURP KIAA0332 SR140 | NQTPAHVYYRWKLYsILQGDsPtKWRTEDFRMFKNGSFWRP |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60716 | S252 | Sugiyama | CTNND1 KIAA0384 | sRVtRIEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDL |
| O94826 | S91 | Sugiyama | TOMM70 KIAA0719 TOM70 TOMM70A | RGDASGLKRNSERKtPEGRAsPAPGsGHPEGPGAHLDMNsL |
| O95273 | S313 | GPS6 | CCNDBP1 DIP1 GCIP HHM | LSIYPPMCHLTVRINSAKLVsVLKKALEITKASHVTPQPED |
| O95273 | S356 | GPS6 | CCNDBP1 DIP1 GCIP HHM | IPLLINAIDHCMNRIKELTQsELEL________________ |
| O95373 | T968 | Sugiyama | IPO7 RANBP7 | IIDDEDNPVDEYQIFKAIFQtIQNRNPVWyQALTHGLNEEQ |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P04049 | T638 | Sugiyama | RAF1 RAF | RsAsEPsLHRAAHtEDINACtLttsPRLPVF__________ |
| P04049 | T640 | Sugiyama | RAF1 RAF | AsEPsLHRAAHtEDINACtLttsPRLPVF____________ |
| P04049 | T641 | Sugiyama | RAF1 RAF | sEPsLHRAAHtEDINACtLttsPRLPVF_____________ |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04075 | T49 | Sugiyama | ALDOA ALDA | GILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtADDR |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05455 | T120 | Sugiyama | SSB | VTDEyKNDVKNRsVYIKGFPtDAtLDDIKEWLEDKGQVLNI |
| P05787 | S74 | EPSD|PSP | KRT8 CYK8 | YGGASGMGGITAVtVNQSLLsPLVLEVDPNIQAVRTQEKEQ |
| P06733 | T100 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | KKLNVtEQEKIDKLMIEMDGtENKsKFGANAILGVsLAVCK |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P07195 | T18 | Sugiyama | LDHB | ___MATLKEKLIAPVAEEEAtVPNNKITVVGVGQVGMACAI |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07237 | T453 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | EAVKVHsFPtLKFFPAsADRtVIDyNGERtLDGFKKFLESG |
| P07437 | T35 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | QIGAKFWEVISDEHGIDPTGtyHGDsDLQLDRIsVyyNEAt |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | T195 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DTGEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIG |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | T190 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P0DPH7 | T51 | Sugiyama | TUBA3C TUBA2 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P10809 | T422 | Sugiyama | HSPD1 HSP60 | AVLKVGGtsDVEVNEKKDRVtDALNAtRAAVEEGIVLGGGC |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T38 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P13987 | T76 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | AGLQVYNKCWKFEHCNFNDVtTRLRENELtyyCCKKDLCNF |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | T50 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | MCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMN |
| P14625 | T148 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GNEELTVKIKCDKEKNLLHVtDtGVGMtREELVKNLGTIAK |
| P14625 | T519 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | DHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIy |
| P17066 | T228 | Sugiyama | HSPA6 HSP70B' | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P17066 | T47 | Sugiyama | HSPA6 HSP70B' | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P17542 | S122 | SIGNOR | TAL1 BHLHA17 SCL TCL5 | APAPASVTAELPGDGRMVQLsPPALAAPAAPGRALLYSLSQ |
| P17812 | S575 | Sugiyama | CTPS1 CTPS | LQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD____ |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18669 | Y26 | Sugiyama | PGAM1 PGAMA CDABP0006 | LVLIRHGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALR |
| P21333 | S1084 | Sugiyama | FLNA FLN FLN1 | PTKPSKVKAFGPGLQGGsAGsPARFtIDTKGAGTGGLGLTV |
| P21980 | T368 | Sugiyama | TGM2 | QPGYEGWQALDPTPQEKsEGtyCCGPVPVRAIKEGDLstKy |
| P22059 | S190 | Sugiyama | OSBP OSBP1 | QRWVTALELAKAKAVKMLAEsDEsGDEEsVsQtDKTELQNT |
| P22059 | S193 | Sugiyama | OSBP OSBP1 | VTALELAKAKAVKMLAEsDEsGDEEsVsQtDKTELQNTLRT |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P23381 | T362 | Sugiyama | WARS1 IFI53 WARS WRS | ALQGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFsGGRD |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P24752 | T185 | Sugiyama | ACAT1 ACAT MAT | RGSTPYGGVKLEDLIVKDGLtDVyNKIHMGsCAENTAKKLN |
| P25786 | T11 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | __________MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQ |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27361 | T202 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MAPK3 ERK1 PRKM3 | ICDFGLARIADPEHDHtGFLtEyVAtRWyRAPEIMLNSKGY |
| P27361 | Y204 | SIGNOR|ELM|iPTMNet|EPSD|PSP | MAPK3 ERK1 PRKM3 | DFGLARIADPEHDHtGFLtEyVAtRWyRAPEIMLNSKGYTK |
| P28482 | T185 | GPS6|SIGNOR|ELM|EPSD | MAPK1 ERK2 PRKM1 PRKM2 | ICDFGLARVADPDHDHtGFLtEyVAtRWyRAPEIMLNSKGY |
| P28482 | Y187 | SIGNOR | MAPK1 ERK2 PRKM1 PRKM2 | DFGLARVADPDHDHtGFLtEyVAtRWyRAPEIMLNSKGYTK |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P30086 | T167 | Sugiyama | PEBP1 PBP PEBP | GKFKVAsFRKKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK |
| P30101 | Y115 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yGVsGyPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPA |
| P34931 | T228 | Sugiyama | HSPA1L | DVSILTIDDGIFEVKAtAGDtHLGGEDFDNRLVsHFVEEFK |
| P34931 | T40 | Sugiyama | HSPA1L | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P35269 | T154 | Sugiyama | GTF2F1 RAP74 | AFEAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHF |
| P35269 | T156 | Sugiyama | GTF2F1 RAP74 | EAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHFSI |
| P35269 | T41 | Sugiyama | GTF2F1 RAP74 | NTTKKyNIMAFNAADKVNFAtWNQARLERDLSNKKIyQEEE |
| P35568 | S307 | SIGNOR | IRS1 | HHLNNPPPSQVGLTRRsRtEsItAtsPAsMVGGKPGsFRVR |
| P36507 | S222 | Sugiyama | MAP2K2 MEK2 MKK2 PRKMK2 | VNSRGEIKLCDFGVsGQLIDsMANsFVGtRSYMAPERLQGT |
| P36507 | S226 | iPTMNet|EPSD|Sugiyama | MAP2K2 MEK2 MKK2 PRKMK2 | GEIKLCDFGVsGQLIDsMANsFVGtRSYMAPERLQGTHYSV |
| P36507 | S26 | iPTMNet|EPSD | MAP2K2 MEK2 MKK2 PRKMK2 | KPVLPALTINPtIAEGPsPtsEGAsEANLVDLQKKLEELEL |
| P36507 | T396 | iPTMNet|EPSD | MAP2K2 MEK2 MKK2 PRKMK2 | EVDFAGWLCKTLRLNQPGtPtRtAV________________ |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P38646 | T87 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKR |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P41091 | T21 | Sugiyama | EIF2S3 EIF2G | MAGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAt |
| P42166 | S159 | Sugiyama | TMPO LAP2 | RKLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsND |
| P42166 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsNDs |
| P42167 | S159 | Sugiyama | TMPO LAP2 | RKLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSND |
| P42167 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSNDS |
| P43034 | T150 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | ATIKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSA |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P45984 | S407 | ELM | MAPK9 JNK2 PRKM9 SAPK1A | PSQSSSINDISSMSTEQtLAsDTDSSLDASTGPLEGCR___ |
| P45984 | T404 | ELM | MAPK9 JNK2 PRKM9 SAPK1A | NATPSQSSSINDISSMSTEQtLAsDTDSSLDASTGPLEGCR |
| P46937 | S109 | Sugiyama | YAP1 YAP65 | RKLPDsFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssP |
| P47712 | S724 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | NIDVIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFL |
| P47756 | T202 | Sugiyama | CAPZB | SGsGtMNLGGsLtRQMEKDEtVsDCsPHIANIGRLVEDMEN |
| P48741 | T228 | Sugiyama | HSPA7 HSP70B | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P48741 | T47 | Sugiyama | HSPA7 HSP70B | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P49840 | Y279 | Sugiyama | GSK3A | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49841 | Y216 | SIGNOR|Sugiyama | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P51149 | T168 | Sugiyama | RAB7A RAB7 | NIPyFEtSAKEAINVEQAFQtIARNALKQETEVELyNEFPE |
| P53779 | T221 | ELM | MAPK10 JNK3 JNK3A PRKM10 SAPK1B | CTLKILDFGLARTAGtsFMMtPyVVtRyYRAPEVILGMGYK |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T39 | Sugiyama | HSPA2 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P55036 | T264 | Sugiyama | PSMD4 MCB1 | AEAGIATTGtEDsDDALLKMtIsQQEFGRTGLPDLSSMTEE |
| P55211 | T125 | SIGNOR|iPTMNet|EPSD | CASP9 MCH6 | NLtPVVLRPEIRKPEVLRPEtPRPVDIGSGGFGDVGALEsL |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60660 | T103 | Sugiyama | MYL6 | QGtyEDyVEGLRVFDKEGNGtVMGAEIRHVLVtLGEKMTEE |
| P60660 | T85 | Sugiyama | MYL6 | LDFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVM |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | T201 | Sugiyama | ACTB | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P60709 | T202 | Sugiyama | ACTB | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62942 | T28 | Sugiyama | FKBP1A FKBP1 FKBP12 | IsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPFK |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63220 | T52 | Sugiyama | RPS21 | IQMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRL |
| P63261 | T201 | Sugiyama | ACTG1 ACTG | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P63261 | T202 | Sugiyama | ACTG1 ACTG | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P68104 | T261 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| P68363 | T51 | Sugiyama | TUBA1B | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P78527 | T2645 | Sugiyama | PRKDC HYRC HYRC1 | LSARWPVAGQIRAtQQQHDFtLtQtADGRssFDWLTGsstD |
| P78527 | T2647 | Sugiyama | PRKDC HYRC HYRC1 | ARWPVAGQIRAtQQQHDFtLtQtADGRssFDWLTGsstDPL |
| P98179 | Y118 | Sugiyama | RBM3 RNPL | GRGRSYSRGGGDQGYGSGRyyDsRPGGyGyGyGRSRDYNGR |
| Q00613 | S363 | Sugiyama | HSF1 HSTF1 | AsVTALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNE |
| Q00613 | T349 | Sugiyama | HSF1 HSTF1 | ALIDsILREsEPAPAsVTALtDARGHTDtEGRPPsPPPtst |
| Q00613 | T357 | Sugiyama | HSF1 HSTF1 | EsEPAPAsVTALtDARGHTDtEGRPPsPPPtstPEKCLsVA |
| Q00613 | T369 | Sugiyama | HSF1 HSTF1 | tDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNELSDHLD |
| Q02543 | S123 | Sugiyama | RPL18A | AGAVtQCyRDMGARHRARAHsIQIMKVEEIAASKCRRPAVK |
| Q02750 | S218 | ELM|Sugiyama | MAP2K1 MEK1 PRKMK1 | VNSRGEIKLCDFGVsGQLIDsMANsFVGtRSYMsPERLQGT |
| Q02750 | S222 | Sugiyama | MAP2K1 MEK1 PRKMK1 | GEIKLCDFGVsGQLIDsMANsFVGtRSYMsPERLQGTHYSV |
| Q02750 | S24 | ELM | MAP2K1 MEK1 PRKMK1 | KKPTPIQLNPAPDGSAVNGtssAETNLEALQKKLEELELDE |
| Q02750 | S25 | ELM | MAP2K1 MEK1 PRKMK1 | KPTPIQLNPAPDGSAVNGtssAETNLEALQKKLEELELDEQ |
| Q02750 | S298 | ELM | MAP2K1 MEK1 PRKMK1 | QVEGDAAEtPPRPRtPGRPLssyGMDsRPPMAIFELLDYIV |
| Q02750 | T23 | ELM | MAP2K1 MEK1 PRKMK1 | KKKPTPIQLNPAPDGSAVNGtssAETNLEALQKKLEELELD |
| Q05639 | T261 | Sugiyama | EEF1A2 EEF1AL STN | PTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRPGMVVTFA |
| Q06830 | T166 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | DLPVGRsVDEtLRLVQAFQFtDKHGEVCPAGWKPGsDtIKP |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q07020 | T85 | Sugiyama | RPL18 | RMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRV |
| Q07666 | S20 | Sugiyama | KHDRBS1 SAM68 | _MQRRDDPAARMsRssGRsGsMDPsGAHPsVRQtPsRQPPL |
| Q12906 | T300 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | ASGIVMPDGSGIYDPCEKEAtDAIGHLDRQQREDItQsAQH |
| Q13009 | S329 | SIGNOR | TIAM1 | SNsMQGRRAKttQDVNAGEGsEFADsGIEGAtTDTDLLSRR |
| Q13247 | S303 | Sugiyama | SRSF6 SFRS6 SRP55 | ENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsPPPKRAT |
| Q13283 | S231 | Sugiyama | G3BP1 G3BP | QEEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsW |
| Q13283 | T241 | Sugiyama | G3BP1 G3BP | ETAPEDAQKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPP |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q15056 | T100 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | KFKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRK |
| Q15293 | S69 | Sugiyama | RCN1 RCN | PPEDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVD |
| Q15293 | T100 | Sugiyama | RCN1 RCN | sKERLGKIVDRIDNDGDGFVttEELKtWIKRVQKRyIFDNV |
| Q15293 | T71 | Sugiyama | RCN1 RCN | EDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRI |
| Q15427 | T14 | Sugiyama | SF3B4 SAP49 | _______MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFL |
| Q15637 | S82 | Sugiyama | SF1 ZFM1 ZNF162 | TRKLRtGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFRTR |
| Q16539 | T180 | ELM | MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A | EDCELKILDFGLARHtDDEMtGyVAtRWYRAPEIMLNWMHY |
| Q16539 | Y182 | ELM | MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A | CELKILDFGLARHtDDEMtGyVAtRWYRAPEIMLNWMHYNQ |
| Q2VIR3 | T21 | Sugiyama | EIF2S3B | MAGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAt |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q53EL6 | S94 | Sugiyama | PDCD4 H731 | GDsVsDsGsDALRSGLtVPtsPKGRLLDRRSRSGKGRGLPK |
| Q53EL6 | T93 | Sugiyama | PDCD4 H731 | RGDsVsDsGsDALRSGLtVPtsPKGRLLDRRSRSGKGRGLP |
| Q562R1 | T107 | Sugiyama | ACTBL2 | WYHTFYNELRVAPDEHPILLtEAPLNPKINREKMTQIMFEA |
| Q58FF6 | T165 | Sugiyama | HSP90AB4P | DHGEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIG |
| Q58FF7 | T169 | Sugiyama | HSP90AB3P HSP90BC | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| Q5VTE0 | T261 | Sugiyama | EEF1A1P5 EEF1AL3 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| Q6GYQ0 | S1000 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | VATITGSESASPVHSPLGSRsQtPsPSTLNIDHMEQKDLQL |
| Q6PEY2 | T51 | Sugiyama | TUBA3E | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q6PKG0 | T747 | Sugiyama | LARP1 KIAA0731 LARP | PPVDPNQEVPPGPPRFQQVPtDALANKLFGAPEPstIARsL |
| Q6UN15 | S492 | Sugiyama | FIP1L1 FIP1 RHE | DRDRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAE |
| Q6UN15 | T494 | Sugiyama | FIP1L1 FIP1 RHE | DRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAERG |
| Q71U36 | T51 | Sugiyama | TUBA1A TUBA3 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q7L2J0 | S216 | Sugiyama | MEPCE BCDIN3 | NLNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPKDIt |
| Q7L2J0 | S217 | Sugiyama | MEPCE BCDIN3 | LNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPKDItD |
| Q7L2J0 | S69 | Sugiyama | MEPCE BCDIN3 | RGPGRCAPsAGsPAAAVGREsPGAAAtsSSGPQAQQHRGGG |
| Q7L2J0 | T213 | Sugiyama | MEPCE BCDIN3 | DPLNLNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPK |
| Q8IWX8 | S815 | Sugiyama | CHERP DAN26 SCAF6 | RSQSRSRSKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIP |
| Q8IWX8 | S817 | Sugiyama | CHERP DAN26 SCAF6 | QSRSRSKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIPDS |
| Q8IWX8 | T819 | Sugiyama | CHERP DAN26 SCAF6 | RSRSKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIPDSRL |
| Q8N684 | S205 | Sugiyama | CPSF7 | IPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLPYF |
| Q8N684 | T203 | Sugiyama | CPSF7 | GGIPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLP |
| Q8NBS9 | T248 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | EQLALGLEHSETVKIGKVDCtQHyELCsGNQVRGyPtLLWF |
| Q96AE4 | Y625 | Sugiyama | FUBP1 | PGGQPDYSAAWAEYYRQQAAyyAQtsPQGMPQHPPAPQGQ_ |
| Q99733 | T28 | Sugiyama | NAP1L4 NAP2 | DGVPsDsVEAAKNAsNtEKLtDQVMQNPRVLAALQERLDNV |
| Q9BQ70 | T86 | Sugiyama | TCF25 KIAA1049 NULP1 FKSG26 | NIDDLEDDPVVNGERsGCALtDAVAPGNKGRGQRGNtEsKt |
| Q9BQE3 | T51 | Sugiyama | TUBA1C TUBA6 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BTA9 | S525 | Sugiyama | WAC KIAA1844 | QGHEPVsPRSLQRsssQRsPsPGPNHtsNssNAsNATVVPQ |
| Q9C0C2 | S672 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TLARAETtQARtEAQDLCRAsPEPPGPEsSSRWLDDLLAsP |
| Q9H2H8 | T153 | Sugiyama | PPIL3 | KLPVNEKtyRPLNDVHIKDItIHANPFAQ____________ |
| Q9H6F5 | S91 | Sugiyama | CCDC86 CYCLON | RLQQGAGLEsPQGQPEPGAAsPQRQQDLHLEsPQRQPEysP |
| Q9H7N4 | S498 | Sugiyama | SCAF1 SFRS19 SRA1 | GGLDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKK |
| Q9H7N4 | S500 | Sugiyama | SCAF1 SFRS19 SRA1 | LDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKKSR |
| Q9NZZ3 | S16 | Sugiyama | CHMP5 C9orf83 SNF7DC2 CGI-34 HSPC177 PNAS-114 PNAS-2 | _____MNRLFGKAKPKAPPPsLtDCIGtVDsRAEsIDKKIS |
| Q9NZZ3 | T18 | Sugiyama | CHMP5 C9orf83 SNF7DC2 CGI-34 HSPC177 PNAS-114 PNAS-2 | ___MNRLFGKAKPKAPPPsLtDCIGtVDsRAEsIDKKISRL |
| Q9UGV2 | T332 | Sugiyama | NDRG3 | GMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQs |
| Q9UQ35 | S1103 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFsA |
| Q9UQ35 | S1648 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | APRALPRRSRSGSSSKGRGPsPEGssstEssPEHPPKSRTA |
| Q9UQ35 | S1652 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | LPRRSRSGSSSKGRGPsPEGssstEssPEHPPKSRTARRGs |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9UQ35 | S876 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | tsPQANEQsVtPQRRsCFEssPDPELKsRtPsRHsCsGssP |
| Q9Y2B0 | S74 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | GsFRINPDGsQsVVEVPyARsEAHLtELLEEICDRMKEyGE |
| Q9Y2V2 | S30 | Sugiyama | CARHSP1 | QPPtHQAsVGLLDtPRsRERsPsPLRGNVVPsPLPtRRtRt |
| Q9Y2V2 | S32 | Sugiyama | CARHSP1 | PtHQAsVGLLDtPRsRERsPsPLRGNVVPsPLPtRRtRtFs |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Interleukin-37 signaling | R-HSA-9008059 | 1.026016e-07 | 6.989 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.953641e-07 | 6.403 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.633311e-06 | 5.579 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 2.742024e-06 | 5.562 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.416919e-06 | 5.466 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.949613e-06 | 5.403 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.130887e-05 | 4.947 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.441593e-05 | 4.612 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.438548e-05 | 4.464 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.441957e-05 | 4.264 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.487753e-05 | 4.261 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 6.294616e-05 | 4.201 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 8.586249e-05 | 4.066 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 7.805656e-05 | 4.108 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 7.459363e-05 | 4.127 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 8.277952e-05 | 4.082 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.377448e-04 | 3.861 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.398676e-04 | 3.854 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.571886e-04 | 3.804 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.902000e-04 | 3.721 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.027591e-04 | 3.693 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.346692e-04 | 3.630 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.469663e-04 | 3.607 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.191550e-04 | 3.659 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.537583e-04 | 3.596 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.453407e-04 | 3.610 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.676494e-04 | 3.572 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.801733e-04 | 3.553 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.014268e-04 | 3.521 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.231387e-04 | 3.491 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.099216e-04 | 3.387 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.354721e-04 | 3.361 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 4.714890e-04 | 3.327 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.912353e-04 | 3.309 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.103972e-04 | 3.292 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.936036e-04 | 3.227 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 6.118527e-04 | 3.213 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 6.401563e-04 | 3.194 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 7.113982e-04 | 3.148 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 6.976345e-04 | 3.156 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 8.114208e-04 | 3.091 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.307019e-04 | 3.081 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.057474e-03 | 2.976 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.075101e-03 | 2.969 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.075101e-03 | 2.969 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.075101e-03 | 2.969 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.078552e-03 | 2.967 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.008912e-03 | 2.996 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.008912e-03 | 2.996 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.004325e-03 | 2.998 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.495529e-04 | 3.022 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.174420e-03 | 2.930 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.135009e-03 | 2.945 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.281226e-03 | 2.892 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.373517e-03 | 2.862 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.354899e-03 | 2.868 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.395945e-03 | 2.855 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.611595e-03 | 2.793 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.556830e-03 | 2.808 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.592623e-03 | 2.798 | 1 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.615894e-03 | 2.792 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.626475e-03 | 2.789 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.844402e-03 | 2.734 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.782396e-03 | 2.749 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.844402e-03 | 2.734 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.944508e-03 | 2.711 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.932421e-03 | 2.714 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.005072e-03 | 2.698 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.122423e-03 | 2.673 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.089832e-03 | 2.680 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.140569e-03 | 2.669 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.037888e-03 | 2.691 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.431753e-03 | 2.614 | 1 | 1 |
| Innate Immune System | R-HSA-168249 | 2.377264e-03 | 2.624 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.431753e-03 | 2.614 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.917435e-03 | 2.535 | 1 | 1 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.917435e-03 | 2.535 | 1 | 1 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.917435e-03 | 2.535 | 1 | 1 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.917435e-03 | 2.535 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.917435e-03 | 2.535 | 1 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.886174e-03 | 2.540 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.881972e-03 | 2.540 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 3.582532e-03 | 2.446 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 3.582532e-03 | 2.446 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 3.761413e-03 | 2.425 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.570553e-03 | 2.447 | 1 | 1 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.761413e-03 | 2.425 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.316569e-03 | 2.479 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.607319e-03 | 2.443 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.544859e-03 | 2.450 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.106068e-03 | 2.387 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.529212e-03 | 2.344 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.680697e-03 | 2.330 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 4.687037e-03 | 2.329 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.711450e-03 | 2.327 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 5.129278e-03 | 2.290 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.788993e-03 | 2.320 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.160642e-03 | 2.287 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.172382e-03 | 2.286 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 5.187504e-03 | 2.285 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 5.437751e-03 | 2.265 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 5.454510e-03 | 2.263 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.670320e-03 | 2.246 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.650864e-03 | 2.248 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.670320e-03 | 2.246 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.093853e-03 | 2.215 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 6.315548e-03 | 2.200 | 1 | 1 |
| MAP2K and MAPK activation | R-HSA-5674135 | 6.315548e-03 | 2.200 | 1 | 1 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 6.315548e-03 | 2.200 | 1 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 6.929007e-03 | 2.159 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.938371e-03 | 2.159 | 0 | 0 |
| Defective Base Excision Repair Associated with OGG1 | R-HSA-9656249 | 7.832495e-03 | 2.106 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 7.917036e-03 | 2.101 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 7.798055e-03 | 2.108 | 1 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 8.133812e-03 | 2.090 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 8.341277e-03 | 2.079 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.498239e-03 | 2.071 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 8.580205e-03 | 2.067 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 8.673711e-03 | 2.062 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 9.324062e-03 | 2.030 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.471714e-03 | 2.024 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 9.963915e-03 | 2.002 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.530917e-03 | 2.021 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.038930e-02 | 1.983 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 9.850805e-03 | 2.007 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.073070e-02 | 1.969 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.098751e-02 | 1.959 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.139112e-02 | 1.943 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.139112e-02 | 1.943 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 1.353165e-02 | 1.869 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.353165e-02 | 1.869 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.353165e-02 | 1.869 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.353165e-02 | 1.869 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 1.353165e-02 | 1.869 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.232967e-02 | 1.909 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.246106e-02 | 1.904 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.246106e-02 | 1.904 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.284685e-02 | 1.891 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.360151e-02 | 1.866 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.360151e-02 | 1.866 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.395642e-02 | 1.855 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.416777e-02 | 1.849 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.475076e-02 | 1.831 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.548393e-02 | 1.810 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.572152e-02 | 1.804 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.611028e-02 | 1.793 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.615785e-02 | 1.792 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.906437e-02 | 1.720 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.719071e-02 | 1.765 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.773696e-02 | 1.751 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.891499e-02 | 1.723 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.777105e-02 | 1.750 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.704509e-02 | 1.768 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.704509e-02 | 1.768 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.968457e-02 | 1.706 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.990324e-02 | 1.701 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.996059e-02 | 1.700 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 2.054898e-02 | 1.687 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.083803e-02 | 1.681 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.097696e-02 | 1.678 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.185934e-02 | 1.660 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.205369e-02 | 1.657 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.212274e-02 | 1.655 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.229163e-02 | 1.652 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.375082e-02 | 1.624 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.408600e-02 | 1.618 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.741016e-02 | 1.562 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.676980e-02 | 1.572 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.582006e-02 | 1.588 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.553570e-02 | 1.593 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.785328e-02 | 1.555 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.699369e-02 | 1.569 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.699369e-02 | 1.569 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.761126e-02 | 1.559 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.870611e-02 | 1.542 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.870611e-02 | 1.542 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.876196e-02 | 1.541 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.876196e-02 | 1.541 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 3.376090e-02 | 1.472 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 3.376090e-02 | 1.472 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 3.376090e-02 | 1.472 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 3.376090e-02 | 1.472 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 3.376090e-02 | 1.472 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 3.376090e-02 | 1.472 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 3.376090e-02 | 1.472 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 3.376090e-02 | 1.472 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.229163e-02 | 1.491 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.937594e-02 | 1.532 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.944905e-02 | 1.531 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 3.376090e-02 | 1.472 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 3.376090e-02 | 1.472 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.143470e-02 | 1.503 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.143470e-02 | 1.503 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.143470e-02 | 1.503 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.143470e-02 | 1.503 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.143470e-02 | 1.503 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 3.376090e-02 | 1.472 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 3.301648e-02 | 1.481 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.310559e-02 | 1.480 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.143470e-02 | 1.503 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.372974e-02 | 1.472 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.978693e-02 | 1.526 | 1 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.310559e-02 | 1.480 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.529976e-02 | 1.452 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.529976e-02 | 1.452 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.529976e-02 | 1.452 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.529976e-02 | 1.452 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.529976e-02 | 1.452 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 3.544883e-02 | 1.450 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.575768e-02 | 1.447 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 4.265908e-02 | 1.370 | 0 | 0 |
| Defective OGG1 Substrate Binding | R-HSA-9656255 | 4.265908e-02 | 1.370 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 4.265908e-02 | 1.370 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 4.265908e-02 | 1.370 | 0 | 0 |
| Defective OGG1 Localization | R-HSA-9657050 | 4.265908e-02 | 1.370 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 4.265908e-02 | 1.370 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 3.805611e-02 | 1.420 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.924533e-02 | 1.406 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 4.317395e-02 | 1.365 | 1 | 1 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.715572e-02 | 1.430 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.016883e-02 | 1.396 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.172105e-02 | 1.380 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 4.181984e-02 | 1.379 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 3.805611e-02 | 1.420 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 3.805611e-02 | 1.420 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.733506e-02 | 1.428 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.408603e-02 | 1.356 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.232919e-02 | 1.373 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 3.924533e-02 | 1.406 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.425960e-02 | 1.354 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.425960e-02 | 1.354 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 4.172105e-02 | 1.380 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 3.805611e-02 | 1.420 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.847531e-02 | 1.415 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.387042e-02 | 1.358 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 3.805611e-02 | 1.420 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.946122e-02 | 1.404 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.079671e-02 | 1.389 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.558253e-02 | 1.341 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.669032e-02 | 1.331 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.832451e-02 | 1.316 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.832451e-02 | 1.316 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 4.832451e-02 | 1.316 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.832451e-02 | 1.316 | 1 | 1 |
| Diseases of Base Excision Repair | R-HSA-9605308 | 4.832451e-02 | 1.316 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.856705e-02 | 1.314 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.902018e-02 | 1.310 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.986533e-02 | 1.302 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.020589e-02 | 1.299 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.141698e-02 | 1.289 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.147286e-02 | 1.288 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.147286e-02 | 1.288 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.147286e-02 | 1.288 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 5.147286e-02 | 1.288 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.147286e-02 | 1.288 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.158139e-02 | 1.288 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 5.287736e-02 | 1.277 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.310697e-02 | 1.275 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.316974e-02 | 1.274 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 5.390286e-02 | 1.268 | 1 | 0 |
| Apoptosis | R-HSA-109581 | 5.567684e-02 | 1.254 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 5.660413e-02 | 1.247 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 7.139163e-02 | 1.146 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.139163e-02 | 1.146 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 7.139163e-02 | 1.146 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.798724e-02 | 1.237 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 6.871606e-02 | 1.163 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.531140e-02 | 1.185 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 5.798724e-02 | 1.237 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 5.716583e-02 | 1.243 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.798724e-02 | 1.237 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 7.001989e-02 | 1.155 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 6.110664e-02 | 1.214 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.070130e-02 | 1.151 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.742712e-02 | 1.241 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 7.001989e-02 | 1.155 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.871420e-02 | 1.231 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 7.001989e-02 | 1.155 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.946737e-02 | 1.226 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.819652e-02 | 1.235 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 6.445647e-02 | 1.191 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.990168e-02 | 1.156 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 6.386420e-02 | 1.195 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 7.158512e-02 | 1.145 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.261811e-02 | 1.139 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.412333e-02 | 1.130 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.443746e-02 | 1.128 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 7.473089e-02 | 1.126 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 7.483800e-02 | 1.126 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 7.624544e-02 | 1.118 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 7.716534e-02 | 1.113 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 7.994902e-02 | 1.097 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.039172e-02 | 1.095 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 8.066170e-02 | 1.093 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.347520e-02 | 1.078 | 0 | 0 |
| Defective OGG1 Substrate Processing | R-HSA-9656256 | 8.350085e-02 | 1.078 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 8.350085e-02 | 1.078 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 8.350085e-02 | 1.078 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 8.350085e-02 | 1.078 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 8.350085e-02 | 1.078 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 8.350085e-02 | 1.078 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 8.350085e-02 | 1.078 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.397007e-02 | 1.076 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 8.401056e-02 | 1.076 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 8.401056e-02 | 1.076 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 8.401056e-02 | 1.076 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 8.401056e-02 | 1.076 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.485512e-02 | 1.071 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 8.657436e-02 | 1.063 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.657436e-02 | 1.063 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.886826e-02 | 1.051 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 8.886826e-02 | 1.051 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 8.886826e-02 | 1.051 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.971881e-02 | 1.047 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 8.986417e-02 | 1.046 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 8.986417e-02 | 1.046 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.029638e-02 | 1.044 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.029638e-02 | 1.044 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.029638e-02 | 1.044 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 9.029638e-02 | 1.044 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.136386e-02 | 1.039 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 1.226026e-01 | 0.912 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 1.226026e-01 | 0.912 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 1.226026e-01 | 0.912 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 1.226026e-01 | 0.912 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 1.226026e-01 | 0.912 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 1.226026e-01 | 0.912 | 0 | 0 |
| Defective SLC12A3 causes Gitelman syndrome (GS) | R-HSA-5619087 | 1.226026e-01 | 0.912 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 1.226026e-01 | 0.912 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 1.226026e-01 | 0.912 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.226026e-01 | 0.912 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 1.226026e-01 | 0.912 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 1.226026e-01 | 0.912 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 1.226026e-01 | 0.912 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 1.226026e-01 | 0.912 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 9.724338e-02 | 1.012 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 9.724338e-02 | 1.012 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.110149e-01 | 0.955 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.062669e-01 | 0.974 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.064410e-01 | 0.973 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.207262e-01 | 0.918 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 9.336738e-02 | 1.030 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 9.336738e-02 | 1.030 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.079183e-01 | 0.967 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 9.796387e-02 | 1.009 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.298044e-02 | 1.032 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 9.298044e-02 | 1.032 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.110149e-01 | 0.955 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 9.740866e-02 | 1.011 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.042071e-01 | 0.982 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 9.724338e-02 | 1.012 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.111923e-01 | 0.954 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.111923e-01 | 0.954 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.064550e-01 | 0.973 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.064550e-01 | 0.973 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.182292e-01 | 0.927 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.960458e-02 | 1.002 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.130138e-01 | 0.947 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.134837e-01 | 0.945 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 1.226026e-01 | 0.912 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 1.110149e-01 | 0.955 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 1.110149e-01 | 0.955 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 1.110149e-01 | 0.955 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.154264e-01 | 0.938 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 9.724338e-02 | 1.012 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.207262e-01 | 0.918 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 1.064410e-01 | 0.973 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.121679e-01 | 0.950 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 9.375772e-02 | 1.028 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 1.248706e-01 | 0.904 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.252553e-01 | 0.902 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.252553e-01 | 0.902 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.252553e-01 | 0.902 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.252553e-01 | 0.902 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.252553e-01 | 0.902 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.252553e-01 | 0.902 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 1.252553e-01 | 0.902 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.275979e-01 | 0.894 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 1.281617e-01 | 0.892 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.317477e-01 | 0.880 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.317477e-01 | 0.880 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.340213e-01 | 0.873 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 1.345826e-01 | 0.871 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.600384e-01 | 0.796 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 1.600384e-01 | 0.796 | 0 | 0 |
| Defective SLC12A1 causes Bartter syndrome 1 (BS1) | R-HSA-5619104 | 1.600384e-01 | 0.796 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 1.958791e-01 | 0.708 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 1.958791e-01 | 0.708 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 1.958791e-01 | 0.708 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 1.958791e-01 | 0.708 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.958791e-01 | 0.708 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.398996e-01 | 0.854 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.398996e-01 | 0.854 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.398996e-01 | 0.854 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.548876e-01 | 0.810 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.701633e-01 | 0.769 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.013753e-01 | 0.696 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.757676e-01 | 0.755 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.975267e-01 | 0.704 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.975267e-01 | 0.704 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.460332e-01 | 0.836 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.579186e-01 | 0.802 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.357833e-01 | 0.867 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.596918e-01 | 0.797 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.398996e-01 | 0.854 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.504018e-01 | 0.823 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.975267e-01 | 0.704 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 1.865638e-01 | 0.729 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.968066e-01 | 0.706 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.386354e-01 | 0.858 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.386354e-01 | 0.858 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.937203e-01 | 0.713 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.504018e-01 | 0.823 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 1.530502e-01 | 0.815 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 1.530502e-01 | 0.815 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 1.530502e-01 | 0.815 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 1.701633e-01 | 0.769 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.773038e-01 | 0.751 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.997904e-01 | 0.699 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 1.515558e-01 | 0.819 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 1.515558e-01 | 0.819 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.857252e-01 | 0.731 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.600384e-01 | 0.796 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.958791e-01 | 0.708 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.398996e-01 | 0.854 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.398996e-01 | 0.854 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 1.701633e-01 | 0.769 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.757676e-01 | 0.755 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.515558e-01 | 0.819 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.006322e-01 | 0.698 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 2.006322e-01 | 0.698 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.446151e-01 | 0.840 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.445453e-01 | 0.840 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.446151e-01 | 0.840 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.651547e-01 | 0.782 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.975267e-01 | 0.704 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.547416e-01 | 0.810 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 1.865638e-01 | 0.729 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.357833e-01 | 0.867 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.495918e-01 | 0.825 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 1.958791e-01 | 0.708 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.893595e-01 | 0.723 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.435838e-01 | 0.843 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.013753e-01 | 0.696 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.721525e-01 | 0.764 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.019095e-01 | 0.695 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.454796e-01 | 0.837 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.019095e-01 | 0.695 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.019095e-01 | 0.695 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 1.445453e-01 | 0.840 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.889067e-01 | 0.724 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.398996e-01 | 0.854 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.701633e-01 | 0.769 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 1.701633e-01 | 0.769 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.856752e-01 | 0.731 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.608189e-01 | 0.794 | 1 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 1.596918e-01 | 0.797 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.615504e-01 | 0.792 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.937203e-01 | 0.713 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.445453e-01 | 0.840 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.445453e-01 | 0.840 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.835618e-01 | 0.736 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 1.547416e-01 | 0.810 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.398996e-01 | 0.854 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.013753e-01 | 0.696 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.765011e-01 | 0.753 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.013753e-01 | 0.696 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.000301e-01 | 0.699 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.547416e-01 | 0.810 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.931277e-01 | 0.714 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.548876e-01 | 0.810 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.701633e-01 | 0.769 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.856752e-01 | 0.731 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 1.712443e-01 | 0.766 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.025591e-01 | 0.693 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.053259e-01 | 0.688 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.070672e-01 | 0.684 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.079719e-01 | 0.682 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.086403e-01 | 0.681 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 2.086403e-01 | 0.681 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.086403e-01 | 0.681 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.301926e-01 | 0.638 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.301926e-01 | 0.638 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.301926e-01 | 0.638 | 0 | 0 |
| Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate | R-HSA-2978092 | 2.301926e-01 | 0.638 | 0 | 0 |
| Signaling by LRP5 mutants | R-HSA-5339717 | 2.301926e-01 | 0.638 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.630438e-01 | 0.580 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.630438e-01 | 0.580 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.944951e-01 | 0.531 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 2.944951e-01 | 0.531 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 3.246059e-01 | 0.489 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.172195e-01 | 0.663 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.534334e-01 | 0.452 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.534334e-01 | 0.452 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.534334e-01 | 0.452 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.534334e-01 | 0.452 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.534334e-01 | 0.452 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.534334e-01 | 0.452 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.491799e-01 | 0.603 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.810321e-01 | 0.419 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.810321e-01 | 0.419 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 3.810321e-01 | 0.419 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.812676e-01 | 0.551 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.074543e-01 | 0.390 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 4.074543e-01 | 0.390 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 4.074543e-01 | 0.390 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.972814e-01 | 0.527 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.972814e-01 | 0.527 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.972814e-01 | 0.527 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.972814e-01 | 0.527 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 3.132388e-01 | 0.504 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.291155e-01 | 0.483 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 3.291155e-01 | 0.483 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.297436e-01 | 0.639 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.448894e-01 | 0.462 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.448894e-01 | 0.462 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.893705e-01 | 0.539 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 2.893705e-01 | 0.539 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.914025e-01 | 0.407 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.065824e-01 | 0.391 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 4.215768e-01 | 0.375 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.447793e-01 | 0.462 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.184098e-01 | 0.378 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 3.404294e-01 | 0.468 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.710393e-01 | 0.431 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.972814e-01 | 0.527 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 3.936496e-01 | 0.405 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.065824e-01 | 0.391 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.397420e-01 | 0.620 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 3.252197e-01 | 0.488 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 3.328140e-01 | 0.478 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 3.349979e-01 | 0.475 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.215768e-01 | 0.375 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.011519e-01 | 0.521 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.452931e-01 | 0.610 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 2.944951e-01 | 0.531 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.331669e-01 | 0.632 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.074543e-01 | 0.390 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.448894e-01 | 0.462 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.365854e-01 | 0.473 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 3.483882e-01 | 0.458 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 2.630438e-01 | 0.580 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.074543e-01 | 0.390 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 3.914025e-01 | 0.407 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.334346e-01 | 0.632 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.659262e-01 | 0.575 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.261434e-01 | 0.646 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.331669e-01 | 0.632 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.172195e-01 | 0.663 | 1 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.556140e-01 | 0.592 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.301926e-01 | 0.638 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 2.301926e-01 | 0.638 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.301926e-01 | 0.638 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.944951e-01 | 0.531 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.810321e-01 | 0.419 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 4.074543e-01 | 0.390 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.011519e-01 | 0.521 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.480628e-01 | 0.458 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 3.952818e-01 | 0.403 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.011519e-01 | 0.521 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.427282e-01 | 0.615 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.652241e-01 | 0.576 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.291155e-01 | 0.483 | 0 | 0 |
| GABA synthesis | R-HSA-888568 | 2.301926e-01 | 0.638 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 2.630438e-01 | 0.580 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 2.630438e-01 | 0.580 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.944951e-01 | 0.531 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.944951e-01 | 0.531 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 2.944951e-01 | 0.531 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 2.944951e-01 | 0.531 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.944951e-01 | 0.531 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 3.246059e-01 | 0.489 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 3.534334e-01 | 0.452 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 3.810321e-01 | 0.419 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.652241e-01 | 0.576 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.074543e-01 | 0.390 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 2.972814e-01 | 0.527 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.291155e-01 | 0.483 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.672531e-01 | 0.573 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.065824e-01 | 0.391 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.101076e-01 | 0.508 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.328140e-01 | 0.478 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.637603e-01 | 0.579 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 4.068794e-01 | 0.391 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.937500e-01 | 0.405 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.652241e-01 | 0.576 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 3.810321e-01 | 0.419 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 3.184952e-01 | 0.497 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.194940e-01 | 0.659 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.534334e-01 | 0.452 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.252197e-01 | 0.488 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.810321e-01 | 0.419 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.972814e-01 | 0.527 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.055771e-01 | 0.392 | 1 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.975790e-01 | 0.401 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.301926e-01 | 0.638 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 2.630438e-01 | 0.580 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.534334e-01 | 0.452 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 4.074543e-01 | 0.390 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.198608e-01 | 0.495 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.190853e-01 | 0.496 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 3.306300e-01 | 0.481 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.652241e-01 | 0.576 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.427282e-01 | 0.615 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 3.448894e-01 | 0.462 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.057539e-01 | 0.515 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.253592e-01 | 0.647 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 2.205787e-01 | 0.656 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.914025e-01 | 0.407 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.914025e-01 | 0.407 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.282155e-01 | 0.642 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.301926e-01 | 0.638 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.944951e-01 | 0.531 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.246059e-01 | 0.489 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.534334e-01 | 0.452 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.534334e-01 | 0.452 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 3.810321e-01 | 0.419 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 3.810321e-01 | 0.419 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 4.074543e-01 | 0.390 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 4.074543e-01 | 0.390 | 1 | 1 |
| Cleavage of the damaged purine | R-HSA-110331 | 3.011519e-01 | 0.521 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.561773e-01 | 0.448 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.719237e-01 | 0.566 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 3.545664e-01 | 0.450 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.198886e-01 | 0.658 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 2.768041e-01 | 0.558 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.633709e-01 | 0.440 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.776243e-01 | 0.557 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.141020e-01 | 0.669 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.068794e-01 | 0.391 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.491799e-01 | 0.603 | 1 | 1 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.246059e-01 | 0.489 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.246059e-01 | 0.489 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.804869e-01 | 0.552 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 4.166252e-01 | 0.380 | 1 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.172195e-01 | 0.663 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.968809e-01 | 0.527 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 3.605404e-01 | 0.443 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.180279e-01 | 0.661 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.302690e-01 | 0.481 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.218611e-01 | 0.654 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 2.549389e-01 | 0.594 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.785982e-01 | 0.555 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.301926e-01 | 0.638 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.301926e-01 | 0.638 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 2.944951e-01 | 0.531 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 2.944951e-01 | 0.531 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.246059e-01 | 0.489 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.172195e-01 | 0.663 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.534334e-01 | 0.452 | 0 | 0 |
| RSK activation | R-HSA-444257 | 3.810321e-01 | 0.419 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.074543e-01 | 0.390 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.471755e-01 | 0.459 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.741330e-01 | 0.427 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.132388e-01 | 0.504 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.914025e-01 | 0.407 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.155046e-01 | 0.501 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.056794e-01 | 0.515 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.074543e-01 | 0.390 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 4.074543e-01 | 0.390 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 3.940658e-01 | 0.404 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.263225e-01 | 0.486 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.556251e-01 | 0.592 | 1 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.074543e-01 | 0.390 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.944951e-01 | 0.531 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.246059e-01 | 0.489 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.074543e-01 | 0.390 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.074543e-01 | 0.390 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 2.587073e-01 | 0.587 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.670004e-01 | 0.573 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 3.914025e-01 | 0.407 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.365854e-01 | 0.473 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.719178e-01 | 0.430 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.427282e-01 | 0.615 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 3.013324e-01 | 0.521 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 2.297436e-01 | 0.639 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.115146e-01 | 0.675 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.228140e-01 | 0.652 | 1 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 4.074543e-01 | 0.390 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 4.074543e-01 | 0.390 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.605404e-01 | 0.443 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 2.165758e-01 | 0.664 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.297436e-01 | 0.639 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 3.448894e-01 | 0.462 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.017109e-01 | 0.520 | 1 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.719650e-01 | 0.565 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.605404e-01 | 0.443 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.215768e-01 | 0.375 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.297436e-01 | 0.639 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.215768e-01 | 0.375 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 3.476480e-01 | 0.459 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.643530e-01 | 0.438 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.074543e-01 | 0.390 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.652241e-01 | 0.576 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 3.291155e-01 | 0.483 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 3.410599e-01 | 0.467 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.312563e-01 | 0.636 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.247710e-01 | 0.488 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 2.427282e-01 | 0.615 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.369408e-01 | 0.625 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.445814e-01 | 0.612 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.802818e-01 | 0.552 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.643530e-01 | 0.438 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.298653e-01 | 0.367 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.313922e-01 | 0.365 | 1 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.323556e-01 | 0.364 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.327502e-01 | 0.364 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 4.327502e-01 | 0.364 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.327502e-01 | 0.364 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.327502e-01 | 0.364 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.327502e-01 | 0.364 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 4.327502e-01 | 0.364 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 4.327502e-01 | 0.364 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.327502e-01 | 0.364 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 4.327502e-01 | 0.364 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.327502e-01 | 0.364 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.339459e-01 | 0.363 | 1 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 4.363738e-01 | 0.360 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 4.363738e-01 | 0.360 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 4.419340e-01 | 0.355 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.452350e-01 | 0.351 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 4.509629e-01 | 0.346 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.509629e-01 | 0.346 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 4.509629e-01 | 0.346 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 4.509629e-01 | 0.346 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.514638e-01 | 0.345 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.514638e-01 | 0.345 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.525233e-01 | 0.344 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.569677e-01 | 0.340 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.569677e-01 | 0.340 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.569677e-01 | 0.340 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.569677e-01 | 0.340 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 4.580070e-01 | 0.339 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.592789e-01 | 0.338 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.609405e-01 | 0.336 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.609405e-01 | 0.336 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.609405e-01 | 0.336 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.637127e-01 | 0.334 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 4.653351e-01 | 0.332 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.653351e-01 | 0.332 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 4.663377e-01 | 0.331 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.748009e-01 | 0.323 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 4.776867e-01 | 0.321 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.790517e-01 | 0.320 | 1 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 4.794821e-01 | 0.319 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.794821e-01 | 0.319 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 4.794821e-01 | 0.319 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.794821e-01 | 0.319 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.801527e-01 | 0.319 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 4.801527e-01 | 0.319 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.801527e-01 | 0.319 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.801527e-01 | 0.319 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 4.801527e-01 | 0.319 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.801527e-01 | 0.319 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.857825e-01 | 0.314 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.857825e-01 | 0.314 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 4.890113e-01 | 0.311 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.890113e-01 | 0.311 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 4.933971e-01 | 0.307 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 4.933971e-01 | 0.307 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.966522e-01 | 0.304 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.966522e-01 | 0.304 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.982356e-01 | 0.303 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.023491e-01 | 0.299 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.023491e-01 | 0.299 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.023491e-01 | 0.299 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.023491e-01 | 0.299 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.023491e-01 | 0.299 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 5.023491e-01 | 0.299 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 5.023491e-01 | 0.299 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.023491e-01 | 0.299 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 5.023491e-01 | 0.299 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.023491e-01 | 0.299 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.023491e-01 | 0.299 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 5.023491e-01 | 0.299 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.023491e-01 | 0.299 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 5.070740e-01 | 0.295 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.070740e-01 | 0.295 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.070740e-01 | 0.295 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.070740e-01 | 0.295 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.070740e-01 | 0.295 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 5.070740e-01 | 0.295 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.070740e-01 | 0.295 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 5.070740e-01 | 0.295 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.074054e-01 | 0.295 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.136438e-01 | 0.289 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.164644e-01 | 0.287 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.205079e-01 | 0.284 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.205079e-01 | 0.284 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.205079e-01 | 0.284 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 5.205079e-01 | 0.284 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.218860e-01 | 0.282 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.235991e-01 | 0.281 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.235991e-01 | 0.281 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 5.235991e-01 | 0.281 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 5.235991e-01 | 0.281 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.235991e-01 | 0.281 | 1 | 1 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.235991e-01 | 0.281 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.235991e-01 | 0.281 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.235991e-01 | 0.281 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.285446e-01 | 0.277 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.336946e-01 | 0.273 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 5.336946e-01 | 0.273 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.336946e-01 | 0.273 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 5.336946e-01 | 0.273 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 5.336946e-01 | 0.273 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 5.336946e-01 | 0.273 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 5.336946e-01 | 0.273 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.343791e-01 | 0.272 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 5.369631e-01 | 0.270 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.389229e-01 | 0.268 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.430405e-01 | 0.265 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 5.432114e-01 | 0.265 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.439430e-01 | 0.264 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.439430e-01 | 0.264 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.439430e-01 | 0.264 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 5.439430e-01 | 0.264 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 5.439430e-01 | 0.264 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.439430e-01 | 0.264 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.439430e-01 | 0.264 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 5.439430e-01 | 0.264 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.439430e-01 | 0.264 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 5.439430e-01 | 0.264 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.439430e-01 | 0.264 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 5.466307e-01 | 0.262 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.466307e-01 | 0.262 | 1 | 0 |
| PI Metabolism | R-HSA-1483255 | 5.470371e-01 | 0.262 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.491692e-01 | 0.260 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.505521e-01 | 0.259 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.538314e-01 | 0.257 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 5.575911e-01 | 0.254 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 5.580781e-01 | 0.253 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.593135e-01 | 0.252 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 5.606133e-01 | 0.251 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.634192e-01 | 0.249 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.634192e-01 | 0.249 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 5.634192e-01 | 0.249 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.634192e-01 | 0.249 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.634192e-01 | 0.249 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.634192e-01 | 0.249 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 5.634192e-01 | 0.249 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.634192e-01 | 0.249 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.634192e-01 | 0.249 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 5.634192e-01 | 0.249 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 5.634192e-01 | 0.249 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.634192e-01 | 0.249 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.634192e-01 | 0.249 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.634192e-01 | 0.249 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.692533e-01 | 0.245 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.712043e-01 | 0.243 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.717411e-01 | 0.243 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 5.717411e-01 | 0.243 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 5.776494e-01 | 0.238 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.790859e-01 | 0.237 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.790859e-01 | 0.237 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.820649e-01 | 0.235 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 5.820649e-01 | 0.235 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 5.820649e-01 | 0.235 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 5.820649e-01 | 0.235 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.820649e-01 | 0.235 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.820649e-01 | 0.235 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.820649e-01 | 0.235 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 5.820649e-01 | 0.235 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 5.820649e-01 | 0.235 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 5.820649e-01 | 0.235 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 5.820649e-01 | 0.235 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 5.820649e-01 | 0.235 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.820649e-01 | 0.235 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.820649e-01 | 0.235 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.820649e-01 | 0.235 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.820649e-01 | 0.235 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.820649e-01 | 0.235 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 5.820649e-01 | 0.235 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 5.824268e-01 | 0.235 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 5.839122e-01 | 0.234 | 0 | 0 |
| S Phase | R-HSA-69242 | 5.858450e-01 | 0.232 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.887760e-01 | 0.230 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.921113e-01 | 0.228 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.958260e-01 | 0.225 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 5.958260e-01 | 0.225 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 5.998858e-01 | 0.222 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 5.999153e-01 | 0.222 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 5.999153e-01 | 0.222 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.999153e-01 | 0.222 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 5.999153e-01 | 0.222 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 5.999153e-01 | 0.222 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.999153e-01 | 0.222 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 5.999153e-01 | 0.222 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 5.999153e-01 | 0.222 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.999153e-01 | 0.222 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 5.999153e-01 | 0.222 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 5.999153e-01 | 0.222 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.053421e-01 | 0.218 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.071471e-01 | 0.217 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 6.074822e-01 | 0.216 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.074822e-01 | 0.216 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.074822e-01 | 0.216 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.074822e-01 | 0.216 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 6.074822e-01 | 0.216 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.077210e-01 | 0.216 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.077210e-01 | 0.216 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 6.143322e-01 | 0.212 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.169729e-01 | 0.210 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.170044e-01 | 0.210 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 6.170044e-01 | 0.210 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 6.170044e-01 | 0.210 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.170044e-01 | 0.210 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 6.170044e-01 | 0.210 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.264137e-01 | 0.203 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 6.300236e-01 | 0.201 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.300236e-01 | 0.201 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.300236e-01 | 0.201 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.300236e-01 | 0.201 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 6.300236e-01 | 0.201 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.300236e-01 | 0.201 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.333645e-01 | 0.198 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.333645e-01 | 0.198 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.333645e-01 | 0.198 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.333645e-01 | 0.198 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.333645e-01 | 0.198 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 6.350295e-01 | 0.197 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 6.388014e-01 | 0.195 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 6.409105e-01 | 0.193 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 6.409105e-01 | 0.193 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 6.415817e-01 | 0.193 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 6.438325e-01 | 0.191 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.490267e-01 | 0.188 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.490267e-01 | 0.188 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 6.490267e-01 | 0.188 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.490267e-01 | 0.188 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.490267e-01 | 0.188 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.490267e-01 | 0.188 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.490267e-01 | 0.188 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.515435e-01 | 0.186 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 6.515435e-01 | 0.186 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.609853e-01 | 0.180 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.609853e-01 | 0.180 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.609853e-01 | 0.180 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.609853e-01 | 0.180 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.619244e-01 | 0.179 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.619244e-01 | 0.179 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 6.619244e-01 | 0.179 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 6.619244e-01 | 0.179 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.623581e-01 | 0.179 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.640208e-01 | 0.178 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.640208e-01 | 0.178 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.640208e-01 | 0.178 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.640208e-01 | 0.178 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.640208e-01 | 0.178 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 6.640208e-01 | 0.178 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.640208e-01 | 0.178 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.640208e-01 | 0.178 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 6.640208e-01 | 0.178 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.693346e-01 | 0.174 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.693346e-01 | 0.174 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.693346e-01 | 0.174 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 6.720553e-01 | 0.173 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 6.720553e-01 | 0.173 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 6.720553e-01 | 0.173 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.720553e-01 | 0.173 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 6.720553e-01 | 0.173 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 6.720553e-01 | 0.173 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 6.720553e-01 | 0.173 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 6.775325e-01 | 0.169 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.783751e-01 | 0.169 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.783751e-01 | 0.169 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 6.783751e-01 | 0.169 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.783751e-01 | 0.169 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 6.783751e-01 | 0.169 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 6.783751e-01 | 0.169 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 6.783751e-01 | 0.169 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.783751e-01 | 0.169 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.817796e-01 | 0.166 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.915768e-01 | 0.160 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 6.915768e-01 | 0.160 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.921171e-01 | 0.160 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.921171e-01 | 0.160 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.921171e-01 | 0.160 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 6.921171e-01 | 0.160 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.921171e-01 | 0.160 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 6.921171e-01 | 0.160 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 6.921171e-01 | 0.160 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 6.921171e-01 | 0.160 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.921171e-01 | 0.160 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.993090e-01 | 0.155 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 7.003917e-01 | 0.155 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 7.012200e-01 | 0.154 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.052726e-01 | 0.152 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 7.052726e-01 | 0.152 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.052726e-01 | 0.152 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.052726e-01 | 0.152 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.052726e-01 | 0.152 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.052726e-01 | 0.152 | 1 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.052726e-01 | 0.152 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.088154e-01 | 0.149 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 7.101303e-01 | 0.149 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 7.178669e-01 | 0.144 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.178669e-01 | 0.144 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 7.178669e-01 | 0.144 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.178669e-01 | 0.144 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.178669e-01 | 0.144 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.178669e-01 | 0.144 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.178669e-01 | 0.144 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.182374e-01 | 0.144 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 7.190519e-01 | 0.143 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 7.193183e-01 | 0.143 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.235597e-01 | 0.141 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.277411e-01 | 0.138 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 7.277411e-01 | 0.138 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 7.299237e-01 | 0.137 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 7.299237e-01 | 0.137 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.299237e-01 | 0.137 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.299237e-01 | 0.137 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.299237e-01 | 0.137 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.299237e-01 | 0.137 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.299237e-01 | 0.137 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 7.299237e-01 | 0.137 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 7.299237e-01 | 0.137 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 7.307105e-01 | 0.136 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 7.348810e-01 | 0.134 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 7.362016e-01 | 0.133 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.362016e-01 | 0.133 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.362016e-01 | 0.133 | 1 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.377152e-01 | 0.132 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.377152e-01 | 0.132 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.378504e-01 | 0.132 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.378504e-01 | 0.132 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 7.414659e-01 | 0.130 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.414659e-01 | 0.130 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.414659e-01 | 0.130 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.414659e-01 | 0.130 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.414659e-01 | 0.130 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 7.414659e-01 | 0.130 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 7.414659e-01 | 0.130 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.414659e-01 | 0.130 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.414659e-01 | 0.130 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.414659e-01 | 0.130 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 7.444370e-01 | 0.128 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 7.487640e-01 | 0.126 | 0 | 0 |
| Disease | R-HSA-1643685 | 7.511397e-01 | 0.124 | 1 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 7.511971e-01 | 0.124 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 7.524510e-01 | 0.124 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.525155e-01 | 0.123 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.525155e-01 | 0.123 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.525155e-01 | 0.123 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.525155e-01 | 0.123 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.525155e-01 | 0.123 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 7.525155e-01 | 0.123 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.525155e-01 | 0.123 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 7.525155e-01 | 0.123 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.550187e-01 | 0.122 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.578641e-01 | 0.120 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.602477e-01 | 0.119 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 7.602477e-01 | 0.119 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 7.610965e-01 | 0.119 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 7.610965e-01 | 0.119 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.613979e-01 | 0.118 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.630936e-01 | 0.117 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.630936e-01 | 0.117 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 7.630936e-01 | 0.117 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 7.630936e-01 | 0.117 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.678308e-01 | 0.115 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.678308e-01 | 0.115 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 7.678308e-01 | 0.115 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.705898e-01 | 0.113 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.732201e-01 | 0.112 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.732201e-01 | 0.112 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 7.752044e-01 | 0.111 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 7.752044e-01 | 0.111 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 7.752044e-01 | 0.111 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.767450e-01 | 0.110 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.784153e-01 | 0.109 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.815745e-01 | 0.107 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 7.827639e-01 | 0.106 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.829143e-01 | 0.106 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.829143e-01 | 0.106 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.829143e-01 | 0.106 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.829143e-01 | 0.106 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 7.893393e-01 | 0.103 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 7.893393e-01 | 0.103 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.921947e-01 | 0.101 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.921947e-01 | 0.101 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.921947e-01 | 0.101 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.921947e-01 | 0.101 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.921947e-01 | 0.101 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 7.943999e-01 | 0.100 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.960471e-01 | 0.099 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 7.961088e-01 | 0.099 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 7.961088e-01 | 0.099 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.000203e-01 | 0.097 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 8.010790e-01 | 0.096 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 8.010790e-01 | 0.096 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 8.010790e-01 | 0.096 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.010790e-01 | 0.096 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 8.026851e-01 | 0.095 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.026851e-01 | 0.095 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.055115e-01 | 0.094 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.090724e-01 | 0.092 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.090724e-01 | 0.092 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.090724e-01 | 0.092 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.152748e-01 | 0.089 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 8.152748e-01 | 0.089 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 8.152748e-01 | 0.089 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.162229e-01 | 0.088 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 8.177256e-01 | 0.087 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 8.177256e-01 | 0.087 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 8.177256e-01 | 0.087 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.177256e-01 | 0.087 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.212284e-01 | 0.086 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.212965e-01 | 0.086 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.212965e-01 | 0.086 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 8.255198e-01 | 0.083 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.255198e-01 | 0.083 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.255198e-01 | 0.083 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.255198e-01 | 0.083 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.255198e-01 | 0.083 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.262214e-01 | 0.083 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.313130e-01 | 0.080 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.329811e-01 | 0.079 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 8.329811e-01 | 0.079 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.329811e-01 | 0.079 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.329811e-01 | 0.079 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.329811e-01 | 0.079 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 8.329811e-01 | 0.079 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 8.358502e-01 | 0.078 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 8.383179e-01 | 0.077 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 8.389343e-01 | 0.076 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 8.401237e-01 | 0.076 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.401237e-01 | 0.076 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.401237e-01 | 0.076 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.401237e-01 | 0.076 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.401237e-01 | 0.076 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.401237e-01 | 0.076 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.401237e-01 | 0.076 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.469614e-01 | 0.072 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.469614e-01 | 0.072 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 8.469614e-01 | 0.072 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 8.469614e-01 | 0.072 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.469614e-01 | 0.072 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.469614e-01 | 0.072 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.469614e-01 | 0.072 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.469614e-01 | 0.072 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.473108e-01 | 0.072 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.474656e-01 | 0.072 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 8.500302e-01 | 0.071 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 8.535069e-01 | 0.069 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.535069e-01 | 0.069 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.535069e-01 | 0.069 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.535069e-01 | 0.069 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.535069e-01 | 0.069 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 8.535069e-01 | 0.069 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 8.538587e-01 | 0.069 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 8.587286e-01 | 0.066 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 8.589168e-01 | 0.066 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 8.597730e-01 | 0.066 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.597730e-01 | 0.066 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.620224e-01 | 0.064 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.634496e-01 | 0.064 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 8.634496e-01 | 0.064 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.657713e-01 | 0.063 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.657713e-01 | 0.063 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 8.657713e-01 | 0.063 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.657713e-01 | 0.063 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.657713e-01 | 0.063 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.660096e-01 | 0.062 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 8.680257e-01 | 0.061 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.680257e-01 | 0.061 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 8.680257e-01 | 0.061 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.680865e-01 | 0.061 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 8.715044e-01 | 0.060 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.715134e-01 | 0.060 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 8.715134e-01 | 0.060 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 8.715134e-01 | 0.060 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 8.715134e-01 | 0.060 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.715134e-01 | 0.060 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.715134e-01 | 0.060 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.715134e-01 | 0.060 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.715134e-01 | 0.060 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 8.716544e-01 | 0.060 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.723225e-01 | 0.059 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.724605e-01 | 0.059 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.767579e-01 | 0.057 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.770103e-01 | 0.057 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 8.770103e-01 | 0.057 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.770103e-01 | 0.057 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.770103e-01 | 0.057 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.770103e-01 | 0.057 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.770103e-01 | 0.057 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.770103e-01 | 0.057 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 8.773685e-01 | 0.057 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.784228e-01 | 0.056 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.784228e-01 | 0.056 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.813788e-01 | 0.055 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.822722e-01 | 0.054 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.822722e-01 | 0.054 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.822722e-01 | 0.054 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.822722e-01 | 0.054 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 8.822722e-01 | 0.054 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.822722e-01 | 0.054 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.822722e-01 | 0.054 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 8.849546e-01 | 0.053 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.873094e-01 | 0.052 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.873199e-01 | 0.052 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.888611e-01 | 0.051 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 8.888611e-01 | 0.051 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 8.888611e-01 | 0.051 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 8.888611e-01 | 0.051 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.911810e-01 | 0.050 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.921313e-01 | 0.050 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.921313e-01 | 0.050 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.921313e-01 | 0.050 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 8.944092e-01 | 0.048 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 8.944092e-01 | 0.048 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.944092e-01 | 0.048 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.954862e-01 | 0.048 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.967472e-01 | 0.047 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.967472e-01 | 0.047 | 0 | 0 |
| Methylation | R-HSA-156581 | 8.967472e-01 | 0.047 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 8.967472e-01 | 0.047 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.980239e-01 | 0.047 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.004160e-01 | 0.046 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.011658e-01 | 0.045 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 9.011658e-01 | 0.045 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.011658e-01 | 0.045 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.011658e-01 | 0.045 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.011658e-01 | 0.045 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.011658e-01 | 0.045 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 9.032873e-01 | 0.044 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.053956e-01 | 0.043 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 9.053956e-01 | 0.043 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.053956e-01 | 0.043 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.057443e-01 | 0.043 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.064782e-01 | 0.043 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.064782e-01 | 0.043 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.064782e-01 | 0.043 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.094446e-01 | 0.041 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.133206e-01 | 0.039 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.170309e-01 | 0.038 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 9.179726e-01 | 0.037 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.205826e-01 | 0.036 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.222510e-01 | 0.035 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.222510e-01 | 0.035 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.224532e-01 | 0.035 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.236339e-01 | 0.035 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.239824e-01 | 0.034 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.239824e-01 | 0.034 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 9.272369e-01 | 0.033 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.272369e-01 | 0.033 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.285047e-01 | 0.032 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.293007e-01 | 0.032 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 9.303523e-01 | 0.031 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.303523e-01 | 0.031 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.303523e-01 | 0.031 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.312279e-01 | 0.031 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.320579e-01 | 0.031 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.333345e-01 | 0.030 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.341218e-01 | 0.030 | 1 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.344411e-01 | 0.029 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.346059e-01 | 0.029 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.361891e-01 | 0.029 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.367450e-01 | 0.028 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.372193e-01 | 0.028 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.382565e-01 | 0.028 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.389217e-01 | 0.027 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.389217e-01 | 0.027 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.389217e-01 | 0.027 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.411244e-01 | 0.026 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 9.415374e-01 | 0.026 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.440412e-01 | 0.025 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.452148e-01 | 0.024 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.452148e-01 | 0.024 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.464380e-01 | 0.024 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 9.464380e-01 | 0.024 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.464380e-01 | 0.024 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.464380e-01 | 0.024 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.465865e-01 | 0.024 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.471572e-01 | 0.024 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.485604e-01 | 0.023 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.487322e-01 | 0.023 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.509284e-01 | 0.022 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 9.509284e-01 | 0.022 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.530305e-01 | 0.021 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 9.556417e-01 | 0.020 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.559239e-01 | 0.020 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.560840e-01 | 0.020 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.569689e-01 | 0.019 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.569689e-01 | 0.019 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 9.575018e-01 | 0.019 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.590256e-01 | 0.018 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.605775e-01 | 0.017 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.622668e-01 | 0.017 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.626799e-01 | 0.017 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.632161e-01 | 0.016 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.638838e-01 | 0.016 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.638838e-01 | 0.016 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.658913e-01 | 0.015 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.683314e-01 | 0.014 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.683314e-01 | 0.014 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.696889e-01 | 0.013 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.709882e-01 | 0.013 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.716437e-01 | 0.012 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 9.722320e-01 | 0.012 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.722320e-01 | 0.012 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.722320e-01 | 0.012 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.734225e-01 | 0.012 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.756527e-01 | 0.011 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.764549e-01 | 0.010 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.776961e-01 | 0.010 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.781496e-01 | 0.010 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.787861e-01 | 0.009 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.794899e-01 | 0.009 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.795681e-01 | 0.009 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.808314e-01 | 0.008 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.811919e-01 | 0.008 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.820862e-01 | 0.008 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.842943e-01 | 0.007 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.849681e-01 | 0.007 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.858980e-01 | 0.006 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.864005e-01 | 0.006 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.866103e-01 | 0.006 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.873649e-01 | 0.006 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.889234e-01 | 0.005 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.889424e-01 | 0.005 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.894171e-01 | 0.005 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.894171e-01 | 0.005 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.903063e-01 | 0.004 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.907225e-01 | 0.004 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.908545e-01 | 0.004 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.915021e-01 | 0.004 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.918671e-01 | 0.004 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.919064e-01 | 0.004 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.924741e-01 | 0.003 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.931768e-01 | 0.003 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.932113e-01 | 0.003 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.940190e-01 | 0.003 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.949359e-01 | 0.002 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.949826e-01 | 0.002 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.951982e-01 | 0.002 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.954046e-01 | 0.002 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.964695e-01 | 0.002 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.974036e-01 | 0.001 | 0 | 0 |
| Translation | R-HSA-72766 | 9.976095e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.979169e-01 | 0.001 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.984001e-01 | 0.001 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.987523e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.988749e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.991090e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.991361e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.993653e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.994188e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.995580e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.996958e-01 | 0.000 | 1 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.997000e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.997486e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.997594e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.997797e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.997797e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.997867e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.997995e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.998233e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.998272e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999089e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999360e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999489e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999713e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999724e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999793e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999862e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999926e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999988e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.999994e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.000000e+00 | 0.000 | 1 | 1 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Attenuation phase | R-HSA-3371568 | 1.110223e-16 | 15.955 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.110223e-16 | 15.955 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 4.440892e-16 | 15.353 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 9.148238e-13 | 12.039 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.399614e-12 | 11.469 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.133068e-09 | 8.671 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.115734e-09 | 8.506 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.060359e-09 | 8.514 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.499046e-09 | 8.260 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.010304e-08 | 7.996 | 1 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.671158e-08 | 7.777 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.854529e-08 | 7.732 | 1 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.962754e-08 | 7.402 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 5.444702e-08 | 7.264 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.582231e-07 | 6.801 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.050683e-07 | 6.688 | 1 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.524329e-07 | 6.598 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.015229e-07 | 6.396 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 8.839712e-07 | 6.054 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 9.430923e-07 | 6.025 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 9.430923e-07 | 6.025 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.057894e-06 | 5.976 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.624108e-06 | 5.789 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.962068e-06 | 5.707 | 1 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.105955e-06 | 5.677 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.680090e-06 | 5.572 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.926031e-06 | 5.534 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.081389e-06 | 5.511 | 1 | 1 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.157984e-06 | 5.501 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 4.343974e-06 | 5.362 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.380406e-06 | 5.358 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 4.774488e-06 | 5.321 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.237965e-06 | 5.281 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.469077e-06 | 5.262 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.626450e-06 | 5.250 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 5.725656e-06 | 5.242 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.471257e-06 | 5.189 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 6.574518e-06 | 5.182 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 8.276424e-06 | 5.082 | 1 | 1 |
| Signaling by Interleukins | R-HSA-449147 | 9.723835e-06 | 5.012 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.192820e-05 | 4.923 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.223216e-05 | 4.912 | 1 | 0 |
| Axon guidance | R-HSA-422475 | 1.322700e-05 | 4.879 | 1 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.364010e-05 | 4.865 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.421345e-05 | 4.847 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.450265e-05 | 4.839 | 1 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.529132e-05 | 4.816 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.541243e-05 | 4.812 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.643709e-05 | 4.784 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.905294e-05 | 4.720 | 1 | 1 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.860580e-05 | 4.730 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.007521e-05 | 4.697 | 1 | 1 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.007521e-05 | 4.697 | 1 | 1 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.007521e-05 | 4.697 | 1 | 1 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.007521e-05 | 4.697 | 1 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.380097e-05 | 4.623 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.391389e-05 | 4.621 | 1 | 1 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.197285e-05 | 4.495 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.420895e-05 | 4.466 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 4.391439e-05 | 4.357 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.663079e-05 | 4.331 | 1 | 1 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.357030e-05 | 4.361 | 1 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 4.501482e-05 | 4.347 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.214432e-05 | 4.283 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.749267e-05 | 4.240 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.392036e-05 | 4.194 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.392036e-05 | 4.194 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.392036e-05 | 4.194 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.352028e-05 | 4.197 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 7.578391e-05 | 4.120 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 8.635591e-05 | 4.064 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 9.463173e-05 | 4.024 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 9.463173e-05 | 4.024 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 9.530985e-05 | 4.021 | 1 | 1 |
| Apoptotic execution phase | R-HSA-75153 | 1.028167e-04 | 3.988 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.233431e-04 | 3.909 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.233431e-04 | 3.909 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.250001e-04 | 3.903 | 1 | 1 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.375039e-04 | 3.862 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.382200e-04 | 3.859 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.491366e-04 | 3.826 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.491366e-04 | 3.826 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 1.582369e-04 | 3.801 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.584130e-04 | 3.800 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.640859e-04 | 3.785 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.703140e-04 | 3.769 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.703140e-04 | 3.769 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.792173e-04 | 3.747 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.798989e-04 | 3.745 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.798989e-04 | 3.745 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.866582e-04 | 3.729 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.140810e-04 | 3.669 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.963469e-04 | 3.707 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.140810e-04 | 3.669 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.177239e-04 | 3.662 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.177239e-04 | 3.662 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.247480e-04 | 3.648 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.341770e-04 | 3.630 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.388707e-04 | 3.622 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.393630e-04 | 3.621 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.758426e-04 | 3.559 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.867023e-04 | 3.543 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.707470e-04 | 3.431 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.523874e-04 | 3.453 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.749454e-04 | 3.426 | 1 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.536097e-04 | 3.451 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.200582e-04 | 3.377 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.340203e-04 | 3.362 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.986615e-04 | 3.302 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.986615e-04 | 3.302 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.031651e-04 | 3.298 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.399763e-04 | 3.268 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.429370e-04 | 3.265 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.761725e-04 | 3.239 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 6.500026e-04 | 3.187 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 6.500026e-04 | 3.187 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 6.500026e-04 | 3.187 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 6.500026e-04 | 3.187 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 6.500026e-04 | 3.187 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 6.500026e-04 | 3.187 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 6.500026e-04 | 3.187 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 6.500026e-04 | 3.187 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 6.500026e-04 | 3.187 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 6.500026e-04 | 3.187 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 6.500026e-04 | 3.187 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.883018e-04 | 3.230 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.156641e-04 | 3.211 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 6.665395e-04 | 3.176 | 1 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 6.831975e-04 | 3.165 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 7.585636e-04 | 3.120 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.662140e-04 | 3.116 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 7.662140e-04 | 3.116 | 1 | 1 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.901890e-04 | 3.102 | 1 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.912318e-04 | 3.102 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.172909e-04 | 3.088 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.456534e-04 | 3.073 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.599833e-04 | 3.066 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 8.602141e-04 | 3.065 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 8.602141e-04 | 3.065 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 9.862274e-04 | 3.006 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.056968e-03 | 2.976 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.126197e-03 | 2.948 | 1 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.168330e-03 | 2.932 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.190716e-03 | 2.924 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.240822e-03 | 2.906 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.249991e-03 | 2.903 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.249991e-03 | 2.903 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.249991e-03 | 2.903 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.306811e-03 | 2.884 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.562532e-03 | 2.806 | 1 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.648221e-03 | 2.783 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.721007e-03 | 2.764 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.742300e-03 | 2.759 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.773848e-03 | 2.751 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.818039e-03 | 2.740 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.899850e-03 | 2.721 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.928995e-03 | 2.715 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.979745e-03 | 2.703 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.979745e-03 | 2.703 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.054820e-03 | 2.687 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.244838e-03 | 2.649 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.956010e-03 | 2.709 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.264198e-03 | 2.645 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.322224e-03 | 2.634 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.349858e-03 | 2.629 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.354613e-03 | 2.628 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.452627e-03 | 2.610 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.476848e-03 | 2.606 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.667214e-03 | 2.574 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.844675e-03 | 2.546 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.844675e-03 | 2.546 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.901022e-03 | 2.537 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.171445e-03 | 2.499 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.180879e-03 | 2.497 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.180879e-03 | 2.497 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 3.186723e-03 | 2.497 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 3.186723e-03 | 2.497 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 3.186723e-03 | 2.497 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 3.186723e-03 | 2.497 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 3.186723e-03 | 2.497 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.850590e-03 | 2.414 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.583150e-03 | 2.339 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.039395e-03 | 2.394 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 4.754651e-03 | 2.323 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.597617e-03 | 2.337 | 1 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.406227e-03 | 2.356 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.406227e-03 | 2.356 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.119225e-03 | 2.291 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.339584e-03 | 2.272 | 1 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 5.416371e-03 | 2.266 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 5.554522e-03 | 2.255 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 5.555495e-03 | 2.255 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.604779e-03 | 2.251 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.881421e-03 | 2.231 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.255119e-03 | 2.204 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.255119e-03 | 2.204 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 6.285080e-03 | 2.202 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.285080e-03 | 2.202 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.364998e-03 | 2.196 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.559810e-03 | 2.183 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 6.733359e-03 | 2.172 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 6.885895e-03 | 2.162 | 1 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 6.888037e-03 | 2.162 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 6.888037e-03 | 2.162 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 6.978764e-03 | 2.156 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 7.068348e-03 | 2.151 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 7.191108e-03 | 2.143 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 7.847313e-03 | 2.105 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 7.847313e-03 | 2.105 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 8.283468e-03 | 2.082 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 8.283468e-03 | 2.082 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 8.472702e-03 | 2.072 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 8.472702e-03 | 2.072 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 8.793887e-03 | 2.056 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 9.014641e-03 | 2.045 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.559741e-03 | 2.020 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.047917e-02 | 1.980 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.207670e-02 | 1.918 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.094409e-02 | 1.961 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.094409e-02 | 1.961 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.353923e-02 | 1.868 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.154602e-02 | 1.938 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.139903e-02 | 1.943 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.160176e-02 | 1.935 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.378966e-02 | 1.860 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.397430e-02 | 1.855 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.411222e-02 | 1.850 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 1.492651e-02 | 1.826 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.552034e-02 | 1.809 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.552857e-02 | 1.809 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.701676e-02 | 1.769 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 1.701676e-02 | 1.769 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.701676e-02 | 1.769 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.709029e-02 | 1.767 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.744175e-02 | 1.758 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.745012e-02 | 1.758 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.800226e-02 | 1.745 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.806076e-02 | 1.743 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.806076e-02 | 1.743 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.835203e-02 | 1.736 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.836966e-02 | 1.736 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.920578e-02 | 1.717 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.026858e-02 | 1.693 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.065688e-02 | 1.685 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.328320e-02 | 1.633 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.355024e-02 | 1.628 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.355024e-02 | 1.628 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.357049e-02 | 1.628 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.371250e-02 | 1.625 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.575357e-02 | 1.589 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.624046e-02 | 1.581 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.624046e-02 | 1.581 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.703415e-02 | 1.568 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.755060e-02 | 1.560 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.836177e-02 | 1.547 | 1 | 1 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.836177e-02 | 1.547 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.844778e-02 | 1.546 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.906337e-02 | 1.537 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.906337e-02 | 1.537 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.906337e-02 | 1.537 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.941291e-02 | 1.531 | 1 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.965359e-02 | 1.528 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.965359e-02 | 1.528 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 3.098555e-02 | 1.509 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.107693e-02 | 1.508 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 3.268480e-02 | 1.486 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.280274e-02 | 1.484 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.303107e-02 | 1.481 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 3.413078e-02 | 1.467 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.379358e-02 | 1.471 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.288879e-02 | 1.368 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 3.454950e-02 | 1.462 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.196751e-02 | 1.377 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.372852e-02 | 1.472 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.506773e-02 | 1.455 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.024001e-02 | 1.395 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.663249e-02 | 1.436 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.288879e-02 | 1.368 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.923844e-02 | 1.406 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 4.447814e-02 | 1.352 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.033383e-02 | 1.394 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.052774e-02 | 1.392 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 4.024001e-02 | 1.395 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.372852e-02 | 1.472 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.631197e-02 | 1.440 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 4.447814e-02 | 1.352 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.518352e-02 | 1.454 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.476388e-02 | 1.349 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.624320e-02 | 1.335 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.624320e-02 | 1.335 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.695435e-02 | 1.328 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.853764e-02 | 1.314 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 4.892924e-02 | 1.310 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.946364e-02 | 1.306 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.963034e-02 | 1.304 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.974937e-02 | 1.303 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.037559e-02 | 1.298 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.037559e-02 | 1.298 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.069807e-02 | 1.295 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 5.069807e-02 | 1.295 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 5.069807e-02 | 1.295 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.350443e-02 | 1.272 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.350443e-02 | 1.272 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.350443e-02 | 1.272 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 5.350443e-02 | 1.272 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 5.663211e-02 | 1.247 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 5.721819e-02 | 1.242 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.745047e-02 | 1.241 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.774955e-02 | 1.238 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 5.854309e-02 | 1.233 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 6.067239e-02 | 1.217 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 6.103434e-02 | 1.214 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 6.118080e-02 | 1.213 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.323800e-02 | 1.199 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.323800e-02 | 1.199 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 6.323800e-02 | 1.199 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.323800e-02 | 1.199 | 1 | 1 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 6.394770e-02 | 1.194 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.433460e-02 | 1.192 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 6.780438e-02 | 1.169 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.969506e-02 | 1.157 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 7.018263e-02 | 1.154 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 7.018263e-02 | 1.154 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.314902e-02 | 1.136 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.374425e-02 | 1.132 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.397594e-02 | 1.131 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.582492e-02 | 1.120 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.582492e-02 | 1.120 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.582492e-02 | 1.120 | 0 | 0 |
| RSK activation | R-HSA-444257 | 7.582492e-02 | 1.120 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 7.582492e-02 | 1.120 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 7.745452e-02 | 1.111 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.745452e-02 | 1.111 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.854049e-02 | 1.105 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 7.870096e-02 | 1.104 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.870096e-02 | 1.104 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 7.882164e-02 | 1.103 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 7.882164e-02 | 1.103 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 1.158745e-01 | 0.936 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 1.158745e-01 | 0.936 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.158745e-01 | 0.936 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 8.790493e-02 | 1.056 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 8.790493e-02 | 1.056 | 1 | 1 |
| Binding and entry of HIV virion | R-HSA-173107 | 1.005088e-01 | 0.998 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.005088e-01 | 0.998 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.005088e-01 | 0.998 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.005088e-01 | 0.998 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.135750e-01 | 0.945 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 8.504154e-02 | 1.070 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 9.293097e-02 | 1.032 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 9.293097e-02 | 1.032 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.095640e-01 | 0.960 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 8.445656e-02 | 1.073 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 8.445656e-02 | 1.073 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.035452e-01 | 0.985 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.089689e-01 | 0.963 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.141996e-02 | 1.039 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.141996e-02 | 1.039 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.128178e-01 | 0.948 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 8.504154e-02 | 1.070 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.811521e-02 | 1.055 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.504154e-02 | 1.070 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.005088e-01 | 0.998 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.011096e-01 | 0.995 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.098415e-01 | 0.959 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 8.790493e-02 | 1.056 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 1.168583e-01 | 0.932 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 1.168583e-01 | 0.932 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 1.168583e-01 | 0.932 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.656238e-02 | 1.015 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.155167e-01 | 0.937 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 8.790493e-02 | 1.056 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.135750e-01 | 0.945 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.158745e-01 | 0.936 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.098415e-01 | 0.959 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 8.790493e-02 | 1.056 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 1.135750e-01 | 0.945 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.135750e-01 | 0.945 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 9.656238e-02 | 1.015 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 8.790493e-02 | 1.056 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.005088e-01 | 0.998 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.029036e-01 | 0.988 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.051107e-01 | 0.978 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 8.325277e-02 | 1.080 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.095640e-01 | 0.960 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 8.790493e-02 | 1.056 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.182802e-01 | 0.927 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 1.005088e-01 | 0.998 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.182802e-01 | 0.927 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.466455e-02 | 1.024 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 9.597618e-02 | 1.018 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.079859e-01 | 0.967 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 9.293097e-02 | 1.032 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 1.005088e-01 | 0.998 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.083042e-01 | 0.965 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.182802e-01 | 0.927 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 1.035452e-01 | 0.985 | 1 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.194219e-01 | 0.923 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.194219e-01 | 0.923 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.196234e-01 | 0.922 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.214193e-01 | 0.916 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.230201e-01 | 0.910 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.246713e-01 | 0.904 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.246713e-01 | 0.904 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.246713e-01 | 0.904 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.249497e-01 | 0.903 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.260425e-01 | 0.899 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.260425e-01 | 0.899 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 1.270460e-01 | 0.896 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.270460e-01 | 0.896 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.270460e-01 | 0.896 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.270460e-01 | 0.896 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.270460e-01 | 0.896 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.272443e-01 | 0.895 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.292324e-01 | 0.889 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 1.300717e-01 | 0.886 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.300717e-01 | 0.886 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.310681e-01 | 0.883 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.346672e-01 | 0.871 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.350728e-01 | 0.869 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.372868e-01 | 0.862 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.380652e-01 | 0.860 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.398811e-01 | 0.854 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.408684e-01 | 0.851 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.408684e-01 | 0.851 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.408684e-01 | 0.851 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.408684e-01 | 0.851 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 1.408684e-01 | 0.851 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.409943e-01 | 0.851 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.441910e-01 | 0.841 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 1.446593e-01 | 0.840 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 1.446593e-01 | 0.840 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 1.446593e-01 | 0.840 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.458593e-01 | 0.836 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.458593e-01 | 0.836 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.458693e-01 | 0.836 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.469029e-01 | 0.833 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.514106e-01 | 0.820 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.514391e-01 | 0.820 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 1.514391e-01 | 0.820 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 1.514391e-01 | 0.820 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.514391e-01 | 0.820 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 1.514391e-01 | 0.820 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 1.514391e-01 | 0.820 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.521830e-01 | 0.818 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.549922e-01 | 0.810 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.554818e-01 | 0.808 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.554818e-01 | 0.808 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.554818e-01 | 0.808 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.855752e-01 | 0.731 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.855752e-01 | 0.731 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.855752e-01 | 0.731 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 1.855752e-01 | 0.731 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 1.855752e-01 | 0.731 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.183400e-01 | 0.661 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.183400e-01 | 0.661 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.183400e-01 | 0.661 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.183400e-01 | 0.661 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 2.183400e-01 | 0.661 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.497886e-01 | 0.602 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 2.497886e-01 | 0.602 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 2.497886e-01 | 0.602 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.497886e-01 | 0.602 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 2.497886e-01 | 0.602 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.799738e-01 | 0.553 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 2.799738e-01 | 0.553 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.799738e-01 | 0.553 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.799738e-01 | 0.553 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.799738e-01 | 0.553 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 2.799738e-01 | 0.553 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 2.799738e-01 | 0.553 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.089462e-01 | 0.510 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.089462e-01 | 0.510 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 3.089462e-01 | 0.510 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.839610e-01 | 0.735 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.839610e-01 | 0.735 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.136185e-01 | 0.670 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.652955e-01 | 0.782 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.652955e-01 | 0.782 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.652955e-01 | 0.782 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.652955e-01 | 0.782 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.587771e-01 | 0.587 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.738882e-01 | 0.562 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 1.598515e-01 | 0.796 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 1.755976e-01 | 0.755 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.836620e-01 | 0.736 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.381838e-01 | 0.623 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.001404e-01 | 0.699 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.343093e-01 | 0.630 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.430653e-01 | 0.614 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.041584e-01 | 0.517 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.041584e-01 | 0.517 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.041584e-01 | 0.517 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.048657e-01 | 0.689 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.041584e-01 | 0.517 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.853801e-01 | 0.545 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 1.987227e-01 | 0.702 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 1.987227e-01 | 0.702 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.041584e-01 | 0.517 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.061824e-01 | 0.686 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 2.819832e-01 | 0.550 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 2.193556e-01 | 0.659 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.930569e-01 | 0.533 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.497886e-01 | 0.602 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 2.799738e-01 | 0.553 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.957432e-01 | 0.708 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.889845e-01 | 0.539 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 2.497886e-01 | 0.602 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.264678e-01 | 0.645 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.799738e-01 | 0.553 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.693708e-01 | 0.771 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.061824e-01 | 0.686 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.061824e-01 | 0.686 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 2.490366e-01 | 0.604 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.864436e-01 | 0.729 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.709478e-01 | 0.567 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.640486e-01 | 0.785 | 0 | 0 |
| Activation of BMF and translocation to mitochondria | R-HSA-139910 | 1.855752e-01 | 0.731 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.855752e-01 | 0.731 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 2.497886e-01 | 0.602 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.799738e-01 | 0.553 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.693708e-01 | 0.771 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 3.089462e-01 | 0.510 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.839610e-01 | 0.735 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.587771e-01 | 0.587 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.569971e-01 | 0.804 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.343093e-01 | 0.630 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.819832e-01 | 0.550 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.416484e-01 | 0.617 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.800203e-01 | 0.553 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 2.505640e-01 | 0.601 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.650063e-01 | 0.782 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.693708e-01 | 0.771 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.598515e-01 | 0.796 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 2.321178e-01 | 0.634 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.727346e-01 | 0.564 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.769234e-01 | 0.752 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.598515e-01 | 0.796 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.041584e-01 | 0.517 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.587771e-01 | 0.587 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.587771e-01 | 0.587 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.598515e-01 | 0.796 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.167441e-01 | 0.664 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.755976e-01 | 0.755 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 2.799738e-01 | 0.553 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 1.662168e-01 | 0.779 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 3.060247e-01 | 0.514 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.492119e-01 | 0.603 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.784241e-01 | 0.555 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.697413e-01 | 0.569 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.854400e-01 | 0.732 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 2.595612e-01 | 0.586 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 2.595612e-01 | 0.586 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 2.490366e-01 | 0.604 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 2.697413e-01 | 0.569 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.167441e-01 | 0.664 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.930569e-01 | 0.533 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.193556e-01 | 0.659 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.041584e-01 | 0.517 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.628943e-01 | 0.580 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.229308e-01 | 0.652 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.087905e-01 | 0.680 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.598275e-01 | 0.796 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.490366e-01 | 0.604 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.944094e-01 | 0.531 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.983011e-01 | 0.525 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.676586e-01 | 0.776 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.652955e-01 | 0.782 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.752862e-01 | 0.756 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 2.381838e-01 | 0.623 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 2.170406e-01 | 0.663 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.640037e-01 | 0.785 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.163888e-01 | 0.665 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.587771e-01 | 0.587 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.167441e-01 | 0.664 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.111421e-01 | 0.507 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.183400e-01 | 0.661 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.569971e-01 | 0.804 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.568349e-01 | 0.590 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.327444e-01 | 0.633 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.436765e-01 | 0.613 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.599618e-01 | 0.585 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.599618e-01 | 0.585 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.599618e-01 | 0.585 | 0 | 0 |
| Interleukin-38 signaling | R-HSA-9007892 | 2.183400e-01 | 0.661 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.799738e-01 | 0.553 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.799738e-01 | 0.553 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 3.089462e-01 | 0.510 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.993358e-01 | 0.524 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.977445e-01 | 0.704 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.436765e-01 | 0.613 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.676586e-01 | 0.776 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.755976e-01 | 0.755 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.755976e-01 | 0.755 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.738882e-01 | 0.562 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.673635e-01 | 0.573 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.072473e-01 | 0.513 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.693708e-01 | 0.771 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 3.035959e-01 | 0.518 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.787479e-01 | 0.555 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.697413e-01 | 0.569 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.961897e-01 | 0.707 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.274155e-01 | 0.643 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.286138e-01 | 0.641 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 1.839610e-01 | 0.735 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.040429e-01 | 0.517 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.839610e-01 | 0.735 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.436765e-01 | 0.613 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.587771e-01 | 0.587 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 2.738882e-01 | 0.562 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.111421e-01 | 0.507 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.376286e-01 | 0.624 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.836620e-01 | 0.736 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 1.839610e-01 | 0.735 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.436765e-01 | 0.613 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 2.930569e-01 | 0.533 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.115226e-01 | 0.507 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.135492e-01 | 0.504 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.135492e-01 | 0.504 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.151824e-01 | 0.501 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 3.152774e-01 | 0.501 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.152774e-01 | 0.501 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.152774e-01 | 0.501 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.152774e-01 | 0.501 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.152774e-01 | 0.501 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 3.190419e-01 | 0.496 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.190419e-01 | 0.496 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.190419e-01 | 0.496 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.190419e-01 | 0.496 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.195947e-01 | 0.495 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.201926e-01 | 0.495 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 3.243631e-01 | 0.489 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.243631e-01 | 0.489 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.243631e-01 | 0.489 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.264040e-01 | 0.486 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.264040e-01 | 0.486 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.264040e-01 | 0.486 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.335611e-01 | 0.477 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 3.339620e-01 | 0.476 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 3.339620e-01 | 0.476 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 3.339620e-01 | 0.476 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.349604e-01 | 0.475 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.349604e-01 | 0.475 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.367545e-01 | 0.473 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.367545e-01 | 0.473 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.367545e-01 | 0.473 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.367545e-01 | 0.473 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 3.367545e-01 | 0.473 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.367545e-01 | 0.473 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.367545e-01 | 0.473 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 3.367545e-01 | 0.473 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.367545e-01 | 0.473 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.367545e-01 | 0.473 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.367545e-01 | 0.473 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.367545e-01 | 0.473 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.367545e-01 | 0.473 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.368506e-01 | 0.473 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.375288e-01 | 0.472 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 3.434677e-01 | 0.464 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 3.486426e-01 | 0.458 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.487854e-01 | 0.457 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.487854e-01 | 0.457 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 3.487854e-01 | 0.457 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.487854e-01 | 0.457 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.514948e-01 | 0.454 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.514948e-01 | 0.454 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.514948e-01 | 0.454 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.565338e-01 | 0.448 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.612249e-01 | 0.442 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 3.634454e-01 | 0.440 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 3.634454e-01 | 0.440 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.634454e-01 | 0.440 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.634454e-01 | 0.440 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.634454e-01 | 0.440 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 3.634454e-01 | 0.440 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 3.634454e-01 | 0.440 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.634454e-01 | 0.440 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.634454e-01 | 0.440 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.634454e-01 | 0.440 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.634454e-01 | 0.440 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.634454e-01 | 0.440 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.634454e-01 | 0.440 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.634454e-01 | 0.440 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 3.634957e-01 | 0.440 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.634957e-01 | 0.440 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.634957e-01 | 0.440 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.634957e-01 | 0.440 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 3.634957e-01 | 0.440 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.637485e-01 | 0.439 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 3.644801e-01 | 0.438 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.708027e-01 | 0.431 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.708027e-01 | 0.431 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 3.708027e-01 | 0.431 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 3.708027e-01 | 0.431 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.708027e-01 | 0.431 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.780779e-01 | 0.422 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 3.780779e-01 | 0.422 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 3.780779e-01 | 0.422 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 3.780779e-01 | 0.422 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.796206e-01 | 0.421 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 3.818327e-01 | 0.418 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.818327e-01 | 0.418 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.818327e-01 | 0.418 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.818327e-01 | 0.418 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.879094e-01 | 0.411 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.890637e-01 | 0.410 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.890637e-01 | 0.410 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.890637e-01 | 0.410 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.890637e-01 | 0.410 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.890637e-01 | 0.410 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 3.890637e-01 | 0.410 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.890637e-01 | 0.410 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.890637e-01 | 0.410 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 3.890637e-01 | 0.410 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.890637e-01 | 0.410 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.916964e-01 | 0.407 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.925187e-01 | 0.406 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 3.925187e-01 | 0.406 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.925187e-01 | 0.406 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 3.928192e-01 | 0.406 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.037548e-01 | 0.394 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.037548e-01 | 0.394 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.058195e-01 | 0.392 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.068058e-01 | 0.391 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 4.071296e-01 | 0.390 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 4.077446e-01 | 0.390 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 4.077446e-01 | 0.390 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.136526e-01 | 0.383 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.136526e-01 | 0.383 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.136526e-01 | 0.383 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.136526e-01 | 0.383 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.136526e-01 | 0.383 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 4.136526e-01 | 0.383 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.136526e-01 | 0.383 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 4.136526e-01 | 0.383 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.136526e-01 | 0.383 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.136526e-01 | 0.383 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.136526e-01 | 0.383 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.146328e-01 | 0.382 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.146328e-01 | 0.382 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 4.157488e-01 | 0.381 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.209282e-01 | 0.376 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 4.209282e-01 | 0.376 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 4.209282e-01 | 0.376 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.209282e-01 | 0.376 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.209282e-01 | 0.376 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 4.253601e-01 | 0.371 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.254466e-01 | 0.371 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.275400e-01 | 0.369 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 4.287218e-01 | 0.368 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.328750e-01 | 0.364 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.343908e-01 | 0.362 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 4.348761e-01 | 0.362 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.348761e-01 | 0.362 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.348761e-01 | 0.362 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 4.348761e-01 | 0.362 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.348761e-01 | 0.362 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.348761e-01 | 0.362 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.348761e-01 | 0.362 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.361900e-01 | 0.360 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.361900e-01 | 0.360 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.372532e-01 | 0.359 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 4.372532e-01 | 0.359 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.372532e-01 | 0.359 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.372532e-01 | 0.359 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.372532e-01 | 0.359 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.372532e-01 | 0.359 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 4.372532e-01 | 0.359 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.388502e-01 | 0.358 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.446161e-01 | 0.352 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.454279e-01 | 0.351 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.468574e-01 | 0.350 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.468574e-01 | 0.350 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.468574e-01 | 0.350 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.468574e-01 | 0.350 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.468574e-01 | 0.350 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.486406e-01 | 0.348 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.486406e-01 | 0.348 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.486406e-01 | 0.348 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 4.486406e-01 | 0.348 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 4.486406e-01 | 0.348 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.553972e-01 | 0.342 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.573371e-01 | 0.340 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.574431e-01 | 0.340 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.574431e-01 | 0.340 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.574431e-01 | 0.340 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.599053e-01 | 0.337 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.599053e-01 | 0.337 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.599053e-01 | 0.337 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 4.599053e-01 | 0.337 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.599053e-01 | 0.337 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.599053e-01 | 0.337 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 4.622139e-01 | 0.335 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 4.622139e-01 | 0.335 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.679420e-01 | 0.330 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.711340e-01 | 0.327 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 4.731879e-01 | 0.325 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.755891e-01 | 0.323 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.755891e-01 | 0.323 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.755891e-01 | 0.323 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.755891e-01 | 0.323 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.783494e-01 | 0.320 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.783494e-01 | 0.320 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 4.789214e-01 | 0.320 | 0 | 0 |
| Disease | R-HSA-1643685 | 4.814860e-01 | 0.317 | 1 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.816469e-01 | 0.317 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.816469e-01 | 0.317 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.816469e-01 | 0.317 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.816469e-01 | 0.317 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.816469e-01 | 0.317 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.816469e-01 | 0.317 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 4.816469e-01 | 0.317 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 4.816469e-01 | 0.317 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.816469e-01 | 0.317 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.816469e-01 | 0.317 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.816469e-01 | 0.317 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 4.816469e-01 | 0.317 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.816469e-01 | 0.317 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.816469e-01 | 0.317 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.886608e-01 | 0.311 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.886608e-01 | 0.311 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.887602e-01 | 0.311 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 4.887602e-01 | 0.311 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 4.887602e-01 | 0.311 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 4.887602e-01 | 0.311 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 4.887602e-01 | 0.311 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.887602e-01 | 0.311 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.925918e-01 | 0.308 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.964371e-01 | 0.304 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.988718e-01 | 0.302 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.995551e-01 | 0.301 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 5.017220e-01 | 0.300 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 5.017220e-01 | 0.300 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 5.017220e-01 | 0.300 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.017220e-01 | 0.300 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 5.017220e-01 | 0.300 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 5.017220e-01 | 0.300 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 5.017220e-01 | 0.300 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 5.017220e-01 | 0.300 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 5.025145e-01 | 0.299 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.025145e-01 | 0.299 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.025145e-01 | 0.299 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.025145e-01 | 0.299 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.025145e-01 | 0.299 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 5.025145e-01 | 0.299 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 5.025145e-01 | 0.299 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.089786e-01 | 0.293 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 5.096615e-01 | 0.293 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.096615e-01 | 0.293 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.102074e-01 | 0.292 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 5.144699e-01 | 0.289 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 5.144699e-01 | 0.289 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 5.144699e-01 | 0.289 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 5.144699e-01 | 0.289 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 5.144699e-01 | 0.289 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 5.144699e-01 | 0.289 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.189776e-01 | 0.285 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.189776e-01 | 0.285 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.189776e-01 | 0.285 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.189776e-01 | 0.285 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 5.189776e-01 | 0.285 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.193498e-01 | 0.285 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.221404e-01 | 0.282 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.225433e-01 | 0.282 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.225433e-01 | 0.282 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.225433e-01 | 0.282 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.225433e-01 | 0.282 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 5.225433e-01 | 0.282 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 5.225433e-01 | 0.282 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.225433e-01 | 0.282 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 5.225433e-01 | 0.282 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.225433e-01 | 0.282 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 5.225433e-01 | 0.282 | 0 | 0 |
| S Phase | R-HSA-69242 | 5.228688e-01 | 0.282 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 5.270002e-01 | 0.278 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 5.270002e-01 | 0.278 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 5.270002e-01 | 0.278 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 5.270002e-01 | 0.278 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 5.270002e-01 | 0.278 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 5.323878e-01 | 0.274 | 1 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 5.354070e-01 | 0.271 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.386391e-01 | 0.269 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 5.393097e-01 | 0.268 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 5.393097e-01 | 0.268 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 5.393097e-01 | 0.268 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.393097e-01 | 0.268 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.396439e-01 | 0.268 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 5.417669e-01 | 0.266 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.417669e-01 | 0.266 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.417669e-01 | 0.266 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.417669e-01 | 0.266 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.417669e-01 | 0.266 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.417669e-01 | 0.266 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 5.417669e-01 | 0.266 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.417669e-01 | 0.266 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.417669e-01 | 0.266 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.417669e-01 | 0.266 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.427325e-01 | 0.265 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.482956e-01 | 0.261 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.482956e-01 | 0.261 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.482956e-01 | 0.261 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.513960e-01 | 0.259 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.539624e-01 | 0.257 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 5.543130e-01 | 0.256 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.602176e-01 | 0.252 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.602176e-01 | 0.252 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.602176e-01 | 0.252 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 5.602176e-01 | 0.252 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 5.602176e-01 | 0.252 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.602176e-01 | 0.252 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 5.602176e-01 | 0.252 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 5.602176e-01 | 0.252 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.602176e-01 | 0.252 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.602176e-01 | 0.252 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.615612e-01 | 0.251 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 5.632570e-01 | 0.249 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 5.632570e-01 | 0.249 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 5.632570e-01 | 0.249 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 5.632570e-01 | 0.249 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 5.632570e-01 | 0.249 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.661517e-01 | 0.247 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.672474e-01 | 0.246 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 5.715642e-01 | 0.243 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.718884e-01 | 0.243 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.748912e-01 | 0.240 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.748912e-01 | 0.240 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.748912e-01 | 0.240 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 5.748912e-01 | 0.240 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.765382e-01 | 0.239 | 0 | 0 |
| Translation | R-HSA-72766 | 5.767436e-01 | 0.239 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.779265e-01 | 0.238 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 5.779265e-01 | 0.238 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.779265e-01 | 0.238 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.779265e-01 | 0.238 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.779265e-01 | 0.238 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.779265e-01 | 0.238 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.779265e-01 | 0.238 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.779265e-01 | 0.238 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.779265e-01 | 0.238 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 5.779265e-01 | 0.238 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 5.829422e-01 | 0.234 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.841440e-01 | 0.233 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.857031e-01 | 0.232 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.862978e-01 | 0.232 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 5.862978e-01 | 0.232 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.862978e-01 | 0.232 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.899436e-01 | 0.229 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 5.900598e-01 | 0.229 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.947403e-01 | 0.226 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.949234e-01 | 0.226 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.949234e-01 | 0.226 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.949234e-01 | 0.226 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 5.949234e-01 | 0.226 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 5.949234e-01 | 0.226 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.949234e-01 | 0.226 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.949234e-01 | 0.226 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 5.974762e-01 | 0.224 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 5.974762e-01 | 0.224 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 5.974762e-01 | 0.224 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 6.084262e-01 | 0.216 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.112367e-01 | 0.214 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.112367e-01 | 0.214 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.112367e-01 | 0.214 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.112367e-01 | 0.214 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.112367e-01 | 0.214 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.112367e-01 | 0.214 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.112367e-01 | 0.214 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.112367e-01 | 0.214 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 6.179958e-01 | 0.209 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 6.191481e-01 | 0.208 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 6.191481e-01 | 0.208 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.210728e-01 | 0.207 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.210728e-01 | 0.207 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.268941e-01 | 0.203 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.268941e-01 | 0.203 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.268941e-01 | 0.203 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 6.268941e-01 | 0.203 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 6.268941e-01 | 0.203 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 6.268941e-01 | 0.203 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.295869e-01 | 0.201 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.295869e-01 | 0.201 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 6.296426e-01 | 0.201 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 6.296426e-01 | 0.201 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.327551e-01 | 0.199 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 6.379681e-01 | 0.195 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.379681e-01 | 0.195 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 6.399105e-01 | 0.194 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 6.399105e-01 | 0.194 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 6.399105e-01 | 0.194 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 6.419217e-01 | 0.193 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 6.419217e-01 | 0.193 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.419217e-01 | 0.193 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.419217e-01 | 0.193 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 6.419217e-01 | 0.193 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.419217e-01 | 0.193 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.419217e-01 | 0.193 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 6.419217e-01 | 0.193 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.462156e-01 | 0.190 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 6.471423e-01 | 0.189 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 6.499139e-01 | 0.187 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 6.499530e-01 | 0.187 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.499530e-01 | 0.187 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.499530e-01 | 0.187 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.563450e-01 | 0.183 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.563450e-01 | 0.183 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 6.563450e-01 | 0.183 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.563450e-01 | 0.183 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.563450e-01 | 0.183 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.563450e-01 | 0.183 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 6.563450e-01 | 0.183 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.563450e-01 | 0.183 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 6.563450e-01 | 0.183 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.563450e-01 | 0.183 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 6.563450e-01 | 0.183 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 6.597718e-01 | 0.181 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.611520e-01 | 0.180 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 6.623086e-01 | 0.179 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 6.623086e-01 | 0.179 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.623086e-01 | 0.179 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.681178e-01 | 0.175 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.701537e-01 | 0.174 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.701882e-01 | 0.174 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.701882e-01 | 0.174 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 6.701882e-01 | 0.174 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.701882e-01 | 0.174 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.701882e-01 | 0.174 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.701882e-01 | 0.174 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 6.701882e-01 | 0.174 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 6.701882e-01 | 0.174 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.701882e-01 | 0.174 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 6.701882e-01 | 0.174 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 6.787448e-01 | 0.168 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.787448e-01 | 0.168 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.787448e-01 | 0.168 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.807249e-01 | 0.167 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 6.834745e-01 | 0.165 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.834745e-01 | 0.165 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 6.834745e-01 | 0.165 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.834745e-01 | 0.165 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.834745e-01 | 0.165 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 6.834745e-01 | 0.165 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.834745e-01 | 0.165 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.834745e-01 | 0.165 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 6.854412e-01 | 0.164 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.854412e-01 | 0.164 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 6.854412e-01 | 0.164 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 6.879033e-01 | 0.162 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.889123e-01 | 0.162 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 6.908123e-01 | 0.161 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.961866e-01 | 0.157 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 6.962264e-01 | 0.157 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 6.962264e-01 | 0.157 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 6.968461e-01 | 0.157 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.001933e-01 | 0.155 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.031130e-01 | 0.153 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 7.055758e-01 | 0.151 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 7.083153e-01 | 0.150 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.084653e-01 | 0.150 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.084653e-01 | 0.150 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.084653e-01 | 0.150 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.084653e-01 | 0.150 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.084653e-01 | 0.150 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 7.084653e-01 | 0.150 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 7.084653e-01 | 0.150 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 7.140949e-01 | 0.146 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.140949e-01 | 0.146 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.152292e-01 | 0.146 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.202118e-01 | 0.143 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.202118e-01 | 0.143 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.202118e-01 | 0.143 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 7.202118e-01 | 0.143 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.202118e-01 | 0.143 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.202118e-01 | 0.143 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.202118e-01 | 0.143 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.202118e-01 | 0.143 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 7.213261e-01 | 0.142 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.254430e-01 | 0.139 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.254430e-01 | 0.139 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.285004e-01 | 0.138 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 7.286691e-01 | 0.137 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.305129e-01 | 0.136 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.314857e-01 | 0.136 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.314857e-01 | 0.136 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 7.314857e-01 | 0.136 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.314857e-01 | 0.136 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 7.314857e-01 | 0.136 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.314857e-01 | 0.136 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.347590e-01 | 0.134 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.347590e-01 | 0.134 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 7.384177e-01 | 0.132 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.412814e-01 | 0.130 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.423059e-01 | 0.129 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 7.423059e-01 | 0.129 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.423059e-01 | 0.129 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 7.423059e-01 | 0.129 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 7.423059e-01 | 0.129 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.423059e-01 | 0.129 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.423059e-01 | 0.129 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 7.423059e-01 | 0.129 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.526908e-01 | 0.123 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 7.526908e-01 | 0.123 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.526908e-01 | 0.123 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.526908e-01 | 0.123 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.536343e-01 | 0.123 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 7.600849e-01 | 0.119 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.626578e-01 | 0.118 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 7.626578e-01 | 0.118 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 7.626578e-01 | 0.118 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.626578e-01 | 0.118 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.626578e-01 | 0.118 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.666539e-01 | 0.115 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.680817e-01 | 0.115 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 7.680817e-01 | 0.115 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 7.702635e-01 | 0.113 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 7.719958e-01 | 0.112 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.719958e-01 | 0.112 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 7.719958e-01 | 0.112 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.722237e-01 | 0.112 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.722237e-01 | 0.112 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.722237e-01 | 0.112 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.722237e-01 | 0.112 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.722237e-01 | 0.112 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.736436e-01 | 0.111 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.750252e-01 | 0.111 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.750252e-01 | 0.111 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 7.751433e-01 | 0.111 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 7.814046e-01 | 0.107 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.814046e-01 | 0.107 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.814046e-01 | 0.107 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.814046e-01 | 0.107 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 7.817863e-01 | 0.107 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.930699e-01 | 0.101 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.941365e-01 | 0.100 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.947754e-01 | 0.100 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 7.986727e-01 | 0.098 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.986727e-01 | 0.098 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 7.986727e-01 | 0.098 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.986727e-01 | 0.098 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.986727e-01 | 0.098 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.986727e-01 | 0.098 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 7.986727e-01 | 0.098 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 7.986727e-01 | 0.098 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 7.992961e-01 | 0.097 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 7.996633e-01 | 0.097 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.010102e-01 | 0.096 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.048466e-01 | 0.094 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.052533e-01 | 0.094 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.067891e-01 | 0.093 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.067891e-01 | 0.093 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 8.099166e-01 | 0.092 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 8.129775e-01 | 0.090 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.145787e-01 | 0.089 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.145787e-01 | 0.089 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.145787e-01 | 0.089 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.145787e-01 | 0.089 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.145787e-01 | 0.089 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.145787e-01 | 0.089 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.145787e-01 | 0.089 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.145787e-01 | 0.089 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.145787e-01 | 0.089 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.145787e-01 | 0.089 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.145787e-01 | 0.089 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.145787e-01 | 0.089 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.148122e-01 | 0.089 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.148751e-01 | 0.089 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 8.174742e-01 | 0.088 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.187169e-01 | 0.087 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.220547e-01 | 0.085 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.220547e-01 | 0.085 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.292297e-01 | 0.081 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.292297e-01 | 0.081 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.292297e-01 | 0.081 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 8.361158e-01 | 0.078 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.361158e-01 | 0.078 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 8.361158e-01 | 0.078 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.361158e-01 | 0.078 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.427246e-01 | 0.074 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.427246e-01 | 0.074 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.427246e-01 | 0.074 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.427246e-01 | 0.074 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.490674e-01 | 0.071 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.490674e-01 | 0.071 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 8.490674e-01 | 0.071 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.530308e-01 | 0.069 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.546518e-01 | 0.068 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.547452e-01 | 0.068 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.547452e-01 | 0.068 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.547452e-01 | 0.068 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.549413e-01 | 0.068 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.551547e-01 | 0.068 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.551547e-01 | 0.068 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.551547e-01 | 0.068 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 8.551547e-01 | 0.068 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.551547e-01 | 0.068 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 8.592197e-01 | 0.066 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.609968e-01 | 0.065 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.609968e-01 | 0.065 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.609968e-01 | 0.065 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.666037e-01 | 0.062 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.666037e-01 | 0.062 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.679639e-01 | 0.061 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 8.679639e-01 | 0.061 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.719847e-01 | 0.059 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.719847e-01 | 0.059 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.719847e-01 | 0.059 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.721465e-01 | 0.059 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.762068e-01 | 0.057 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.795313e-01 | 0.056 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.821052e-01 | 0.054 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 8.821052e-01 | 0.054 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 8.821052e-01 | 0.054 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.821052e-01 | 0.054 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 8.821052e-01 | 0.054 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.876850e-01 | 0.052 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.912438e-01 | 0.050 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 8.914268e-01 | 0.050 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.914268e-01 | 0.050 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.914268e-01 | 0.050 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.958078e-01 | 0.048 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.000123e-01 | 0.046 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 9.040474e-01 | 0.044 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.040474e-01 | 0.044 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.046461e-01 | 0.044 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.077379e-01 | 0.042 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.107741e-01 | 0.041 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.116363e-01 | 0.040 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.116363e-01 | 0.040 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.152030e-01 | 0.038 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 9.164596e-01 | 0.038 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.191906e-01 | 0.037 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.219108e-01 | 0.035 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.244026e-01 | 0.034 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 9.250633e-01 | 0.034 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.250633e-01 | 0.034 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.265893e-01 | 0.033 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.265893e-01 | 0.033 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.265893e-01 | 0.033 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.283771e-01 | 0.032 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.302042e-01 | 0.031 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.309922e-01 | 0.031 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.309922e-01 | 0.031 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.337786e-01 | 0.030 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.364527e-01 | 0.029 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.364527e-01 | 0.029 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.364527e-01 | 0.029 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.364527e-01 | 0.029 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.382005e-01 | 0.028 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.390189e-01 | 0.027 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.414817e-01 | 0.026 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 9.438451e-01 | 0.025 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.461132e-01 | 0.024 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.461132e-01 | 0.024 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.461132e-01 | 0.024 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.510766e-01 | 0.022 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.543070e-01 | 0.020 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.545010e-01 | 0.020 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.560348e-01 | 0.020 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.561531e-01 | 0.019 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.596249e-01 | 0.018 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.603450e-01 | 0.018 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.612565e-01 | 0.017 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.612565e-01 | 0.017 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.612565e-01 | 0.017 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.621514e-01 | 0.017 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.628222e-01 | 0.016 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.629902e-01 | 0.016 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.629902e-01 | 0.016 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.629902e-01 | 0.016 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.643248e-01 | 0.016 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.666428e-01 | 0.015 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.671504e-01 | 0.015 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.688254e-01 | 0.014 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.688826e-01 | 0.014 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.697525e-01 | 0.013 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.704680e-01 | 0.013 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.705634e-01 | 0.013 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.709754e-01 | 0.013 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 9.732749e-01 | 0.012 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.735092e-01 | 0.012 | 1 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.743555e-01 | 0.011 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.748266e-01 | 0.011 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.795682e-01 | 0.009 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.797734e-01 | 0.009 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.831086e-01 | 0.007 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.834797e-01 | 0.007 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.837168e-01 | 0.007 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.840566e-01 | 0.007 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.850080e-01 | 0.007 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.853223e-01 | 0.006 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.853223e-01 | 0.006 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.856147e-01 | 0.006 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.867556e-01 | 0.006 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.872917e-01 | 0.006 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.875175e-01 | 0.005 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.878061e-01 | 0.005 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.878061e-01 | 0.005 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.879095e-01 | 0.005 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.887734e-01 | 0.005 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.892279e-01 | 0.005 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.893494e-01 | 0.005 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.900826e-01 | 0.004 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.908696e-01 | 0.004 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.915769e-01 | 0.004 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.923147e-01 | 0.003 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.927684e-01 | 0.003 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.934161e-01 | 0.003 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.937070e-01 | 0.003 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.941512e-01 | 0.003 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.950903e-01 | 0.002 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.954803e-01 | 0.002 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.963882e-01 | 0.002 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.973615e-01 | 0.001 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.978697e-01 | 0.001 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.981827e-01 | 0.001 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.983223e-01 | 0.001 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.988950e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.990243e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.991048e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.992071e-01 | 0.000 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.992702e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.994138e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.996085e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.996093e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.997038e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.997069e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.997719e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.998431e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.998965e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999469e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999664e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999678e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999957e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999979e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999980e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999983e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999990e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999996e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |